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4 Introduction
Breast cancer is the most common cancer diagnosis in women. About 464.000 women were
diagnosed with breast cancer in Europe in 2012 and about 131.000 women died because of
breast cancer [1]. Early detection is crucial to reduce breast cancer mortality. Therefore,
many countries have implemented breast cancer screening programs in which asympto-
matic women are screened regularly to find the breast cancer before it becomes palpable
and symptomatic.
Even though the number of breast cancer deaths is decreasing, the incidence of breast can-
cer is increasing. This can be explained by the ageing of the population [2, 3]. The breast
cancer incidence rates are highest for women between 50-75 years of age. Gender and age
are the most important risk factor for breast cancer and so far the only risk factors that are
considered in population screening. Many other risk factors are known. There are genetic
factors, reproduction and hormonal factors, dietary factors and socioeconomic factors; an
overview is given in Table 1.1. The risk factor breast density is one of the hormonal factors,
as breast density decreases with age and after the menopause. Breast density refers to the
amount of lobes, ducts and epithelial and connective tissue, also called fibroglandular tis-
sue, as compared to the breast volume. This thesis focuses on mammographic breast density
and its potential to be used as stratification tool for personalised breast cancer screening.
1.1 Breast cancer
The breast consists of several lobes that are connected with the nipple through ducts. The
lobes are surrounded by fatty tissue and consist of lobules which are used for milk pro-
duction. Breast cancer can manifest itself in several ways. The classification into different
subtypes is done by a pathologist, who evaluates the tissue samples under the microscope.
The most common breast cancers are the invasive ductal carcinoma (IDC) and the invasive
lobular carcinoma (ILC). Invasive cancers start growing in one type of tissue and spread
then into the surrounding tissue. The lesion might be palpable and visible on the mammo-
gram as a round, oval or irregular mass. Depending on the surrounding tissue, spiculations
might be visible. The IDCs are a group of tumours that fail to exhibit sufficient character-
istics to achieve classification as a specific histological type. The ILC on the other side is
characterised by cells individually dispersed or arranged in single-file linear patterns [11].
Abnormal cells within the ducts or the lobes that did not invade into the surrounding tissue
are called carcinoma in situ. Also here, a differentiation between ductal carcinoma in situ
(DCIS) and lobular carcinoma in situ (LCIS) is possible. DCIS and LCIS are non-obligatory
precursors of cancer. DCIS is much more common than LCIS. Not all in situ carcinomas
evolve into an invasive cancer while most DCIS are intensively treated resulting in a loss of
life quality without any survival benefit.
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6 Introduction
Figure 1.1: A set of mammograms, from the left to right: the right MLO view, the left MLO view,
the right CC view and the left CC view.
1.2 Breast imaging
1.2.1 Mammography
Mammography is the most commonly used breast imaging technique. Mammograms are
acquired within clinical practice and in breast cancer screening programs. To take a mam-
mogram, the breast is positioned on the support plate and compressed with the compression
paddle. Then, X-rays are sent through the breast. Previously, films were used to capture the
image, but since the late 90s film mammography got replaced by full field digital mammo-
graphy. Digital mammograms can be saved in two modes, as ’for processing’ (raw) images
and as ’for presentation’ (processed) images. In raw images, the pixel values saved are
proportional to the measured X-ray intensities. Each vendor has then its own algorithm to
generate the ’for presentation’ images based on the raw pixel data. The ’for presentation’
images are used for evaluation by the radiologist. The X-ray attenuation is different for
fat-involuted, fibroglandular and cancerous tissue. The difference in attenuation leads to
the contrast between the different types of tissue on the mammogram. Fatty tissue is X-ray
transparent and appears black on the mammogram, while fibroglandular tissue and cancer-
ous tissue appear white in the image.
Usually, each breast is imaged in two different directions, the mediolateral oblique (MLO)
view (angled side-view) and the cranio caudal (CC) view (top to bottom). If necessary,
additional images are acquired with different angles, magnification views or spot views on
the request of the radiologist. An exam consisting of the MLO and the CC images of the
right and left breast is shown in Figure 1.1.
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1.3. Breast cancer screening 7
1.2.2 Digital Breast Tomosynthesis (DBT)
Mammography has its limitations; superpositions of fibroglandular tissue layers can ob-
scure a lesion. On top of that, a superposition might look suspicious on the mammogram,
leading to a referral. Digital Breast Tomosynthesis (DBT) has been developed to reduce the
effect of overlapping tissue. As with mammography, the breast is compressed and X-rays
are sent through the breast. The difference between mammography and DBT is the location
of the X-ray source. The source of the X-rays is at a fixed position above the breast for
mammography while the X-ray source is rotating over a limited range of angles over the
breast for DBT. Several low dose X-ray images are acquired which are then used to gener-
ate a three-dimensional image. Instead of having only the projection of the breast into one
image, several slices are reconstructed that prevent the effect of overlapping tissue. Each
slice has a thickness of a few mm and the number of slices depends on the thickness of the
compressed breast.
1.2.3 Magnetic Resonance Imaging (MRI)
With Magnetic Resonance Imaging (MRI) three-dimensional images are acquired. MRI
has a high sensitivity. Therefore, it is used to screen women at a high risk for breast cancer
(BRCA gene mutation carriers). These women are usually younger than the women par-
ticipating in the population screening and they have a higher breast density. Additionally,
MRI is used to locate known cancers within the breast and to estimate the size (volume) of
the cancer. The disadvantage of MRI is, however, that it takes more time to obtain, read
and evaluate the images. Furthermore, contrast agent administration is necessary, limiting
the use of MRI in population screening.
1.2.4 Ultrasound
Breast ultrasound images can be divided into two different groups. First, there is hand
held ultrasound. Images are acquired and evaluated at the same time. The examination is
performed by a radiologist. Hand held ultrasound is used to follow up suspicious regions
in the mammograms or to do an ultrasound guided biopsy. With three-dimensional whole
breast ultrasound it is possible to generate an image of the entire breast that can be evaluated
at a different point in time and that allows temporal comparison. Several volumes are
obtained to cover the entire breast. The evaluation of whole breast ultrasound is very time
consuming.
1.3 Breast cancer screening
Nowadays, most western countries have breast cancer screening programs. Starting at an
age of 40-50 years women are regularly invited to get a mammogram. The interval between
screening rounds varies between countries. The Netherlands has a screening interval of two
511786-L-bw-Holland
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years. Initially women between 50-70 years of age were invited to participate, but given the
increasing life expectancies, women are invited until the age of 75 since 1998.
Within the Dutch program, two radiologists review the mammograms independently. They
refer the women for further investigations and/or imaging to the general practitioner or the
hospital in case of a visible abnormality on the mammogram. Usually, ultrasound images
are acquired and if a region looks suspicious on the ultrasound image, a biopsy is per-
formed. The Netherlands has a rather low referral rate compared to other countries [12].
Women are referred in about 2.5% of the examinations. Most of the time, in about 72% of
the referrals, no cancer is diagnosed. The cancer detection rate is at seven cancers per 1000
women screened [13].
Unfortunately, not all breast cancers are detected within screening programs, about 16-33%
of the cancers is detected in between the screening rounds [14,15]. They are called interval
cancers. Compared to screen-detected cancers, interval cancers are detected in a later stage
with a worse prognosis [16–18]. There are different reasons for a cancer detection outside
the screening program. First, some cancers grow fast and develop from a small undetectable
lesion at the time of screening to a palpable lesion in the screening interval. Second, the le-
sion might have been masked by the surrounding tissue and is therefore not distinguishable
from normal tissue. Last, it is possible that the radiologist did not see the lesion or that the
lesion was interpreted as normal tissue (observer error). Many interval cancers are visible
on the screening mammogram in retrospect [19–21].
1.4 Breast density and masking
Studies have shown that women with high breast density have an up to six times increased
risk for the development of breast cancer compared to women with low breast density
[10, 22–24]. Breast density refers to the amount of fibroglandular tissue within the breast
in comparison to the breast size. Breast density depends on hormonal factors and decreases
with age and the menopause [25].
Fibroglandular tissue and cancerous tissue have the same attenuation for X-rays. They
both appear white on the mammogram while fatty tissue is X-ray transparent and appears
black. As a result, it is not always possible to differentiate fibroglandular tissue from can-
cerous tissue and the cancer remains hidden within the fibroglandular tissue structures. It
is known that the sensitivity of mammography decreases with an increase in breast dens-
ity [26–32]. Therefore, mammography is not the optimal screening modality for all women
and screening programs taking into account breast density and other risk factors are under
discussion [33, 34]. Especially in the United States, breast density is discussed in recent
years. Many states passed breast density legislation, forcing radiologists to inform women
about their breast density and the associated risks. Mammograms with increasing breast
density from left to right are shown in Figure 1.2.
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Figure 1.2: Mammograms with increasing breast density from the left to right.
The classification of breast density and breast density patterns is not new. Already in 1976,
mammograms were categorised into different classes by Wolfe [35]. In 1982, Boyd and
colleagues [36] introduced a scale based on mammographic density percentages. The clas-
sification was performed visually by a radiologist. Nowadays, the ACR BI-RADS density
categories are commonly used in clinical practice. BI-RADS is a four-point categorisa-
tion. The 4th edition (2003) [37] included percentages, and the aim was to estimate the
percentage dense area with respect to the area of the breast on the mammogram. The cat-
egories changed with the publication of the last (5th) edition (2013) [38]. Now, the aim is
to describe the densest part in the mammogram. The masking effect is acknowledged with
these changes. Even though the mammogram is not considered to belong to the highest
density category with the 4th BI-RADS edition, there might be a region that is extremely
dense and it is therefore considered to belong to the highest category with the 5th edition.
Several studies have found considerable inter- and intra-reader variabilities when using the
4th [39–42] and 5th [43, 44] BI-RADS edition, respectively.
To use breast density as a stratification tool, it is necessary to have accurate and reliable
breast density measurements. Furthermore, a continuous measurement might be prefer-
able over a categorical to use breast density in risk models. Several algorithms have been
developed in the past years to automate breast density assessments. Breast density meas-
urements can be divided into two categories, depending on whether they aim to measure
the volume of dense tissue or the area of the projected dense tissue.
Many algorithms have been developed to assign all pixels either to the class ’dense’ or to the
class ’non-dense’. Subsequently, the percentage dense area with respect to the breast area
is determined. The disadvantage of these area based measurements is, that the 3D structure
of the breast is not taken into account and that the measurement is not rotation invariant.
With the introduction of full field digital mammography volumetric breast density meas-
urements became possible. Given the raw data, where the pixel intensity is proportional
to the exposure, the fibroglandular tissue volume can be determined for each pixel lo-
cation using an internal calibration [45–47]. Together with an estimation of the breast
volume, the breast density measurement ’percent dense volume’ is estimated by dividing
511786-L-bw-Holland
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the fibroglandular tissue volume by the breast volume. By thresholding the percent density
estimate, a categorical measure can be obtained that compares well to the BI-RADS density
categories [48–50]. The internal reference method relies on the assumption that the chosen
reference pixel value belongs to the projection of only fatty tissue. However, pixels repres-
enting fat only may not be present in dense breasts, causing an underestimation of density
measurements [51–53]. An overview of breast density algorithms is given in He et al. [54].
Area based measurements with the semi automated program Cumulus [55] were considered
gold standard for risk analysis for a long time. The advantage of this measurement is that
it can be applied to all types of mammograms, film, and raw and processed digital mam-
mograms. Since the transition to digital mammography, studies using volumetric breast
density measurements are published as well. In the study by Eng et al. [24], breast can-
cer risk was estimated based on six breast density measurement techniques and the breast
cancer risk association was strongest with measurements of volumetric breast density.
1.5 Alternatives to mammography and personalised screening
Mammography is the gold standard in population screening and most women are screened
with mammography only. In the Netherlands, only women with a 50% lifetime risk of
developing breast cancer (like BRCA gene mutation carriers, women at familial increased
risk and those with with a prior history of radiation to the chest) have an adjusted screening
scheme. Before introducing personalised screening and changing an entire screening pro-
gram, it is necessary to show that the performance of the new scheme will be better than the
old one. It is necessary to have a higher sensitivity, to find more cancers using the adjusted
scheme than with the old one, and to have a comparable level of the positive predictive
value, which is the ratio between justified referrals and overall referrals. Especially an in-
crease in unjustified referrals should be avoided. Furthermore, it is necessary to keep in
mind that the increase in cancer rate should not only be caused by less aggressive cancers
that will never cause symptoms or death during the woman’s expected lifetime (prevent
increase of over-diagnosis). Last, the screening program should be cost efficient.
In the future, mammography might be replaced with DBT. To date, several (European)
trials are ongoing that investigate the use of DBT in population screening. In the STORM
trial [56] the combination of DBT and mammography is compared to mammography alone.
The combination of DBT with mammography yielded a higher breast cancer detection rate
than only mammography. Recalling based on both modalities separately (positive with
mammography or DBT or positive with both modalities) increased the false positive rate
compared to recalling based on mammography alone (5.5% vs. 2.0%) while recalling when
an abnormality is visible with both modalities decreased the number of unjustified referrals
(1.0%). The false positive rate was estimated as 3.5% in a ’conditional’ setting which means
that an abnormality needs to be visible with DBT. As all cancers were visible with DBT,
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the combination of mammography with DBT could lead to an increase in cancer detec-
tion with a small increase in unjustified referrals (2.0% vs. 3.5%) which is still within the
European recommendations. In the Malmo¨ Breast Tomosynthesis Screening Trial [57] one
view tomosynthesis is compared to two view mammography. Also the Malmo¨ trial showed
an increase in the breast cancer detection rate when using DBT (8.9/1000) compared to
mammography (6.3/1000) and an increase in unjustified referrals (2.6/100 to 3.8/100 for
mammography and DBT, respectively).
Personalised screening could be implemented in two ways, either by replacing mammo-
graphy with another modality or by adding additional imaging to mammography. Based
on the individual risk for the development of breast cancer and of the risk that the cancer
could be missed with mammography, (additional) screening could be offered with MRI
or ultrasound. In the US, several studies were conducted to investigated the benefit of an
additional MRI or ultrasound examination. The combination of mammography with an-
other screening modality leads to an increase in sensitivity at the cost of more false positive
findings [58]. In Japan, a randomised controlled trial was conducted with about 73,000
women [59]. The intervention group got a mammogram and an ultrasonography while the
control group underwent mammography only. Also here, more cancers were found when
adding an ultrasound examination to mammography and more women were unnecessarily
recalled and biopsied. Adding 3D automated breast ultrasound to mammography in wo-
men with dense breasts was investigated in a study by Wilczek et al. [60]. More cancers
were found when adding 3D ultrasound to mammography, while the recall rate increased
slightly and was still within the European recommendations. Additional imaging with MRI
for women with extremely dense breasts is currently under investigation within the Dutch
population screening in the DENSE trial [61].
In recent years, many states of the US passed legislation that requires the radiologists
to inform women about their breast density and possible supplemental imaging options.
Melinkow et al. [62] reviewed supplemental screening for breast cancer in women with
dense breasts. They found that BI-RADS density assessment is generally consistent across
sequential examinations by the same or different readers (at population level), but there was
important variability among readings for individual women and that this variability might
be reducible with automated assessment. They further state, ’Variability in breast density
assignments may lead to unintended consequences. Reclassification from one overall cat-
egory to another (for example, ’dense’ to ’not-dense’ or vice versa) may undermine a wo-
man’s confidence in the screening process and leave her uncertain about her risk for breast
cancer, whereas the opposite reclassification may alarm women unnecessarily or prompt
supplemental screening tests of uncertain value.’. Additionally, it is reported that supple-
mental screening after a negative mammogram leads to additional breast cancer detections,
though the positive predictive value is low which means that there are many false posit-
ives. In conclusion it is said, that it remains open whether supplemental screening leads to
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12 Introduction
improved clinical outcomes, as only cancer rates are investigated and interval cancer rates
and over-diagnosis are not addressed. A need for well-designed, long-term and prospective
studies is stated.
1.6 Thesis outline
The outline of the thesis is as follows: First, the Dutch screening program is evaluated con-
sidering breast density. Amongst other measurements, the sensitivity and specificity of the
program are determined for the four different Volumetric Density Grades (VDG), a scale
comparable to the BI-RADS density categories, obtained with the breast density Software
Volpara (Volpara Health Technologies, Wellington, New Zealand).
The results of Volpara are also used in Chapter 3. When using breast density for stratific-
ation, accurate and reliable measurements are needed over time. The consistency of breast
density categories of serial screening mammograms was evaluated. The performance of the
software was compared to the performance of human readers using BI-RADS.
Previous research has shown that volumetric breast density is easily underestimated in dense
breasts when using an internal calibration to estimate the fibroglandular tissue volume. In
Chapter 4, methods to improve breast density estimations in extremely dense breasts are
investigated. A pipeline that is suitable for all types of breast densities is proposed.
In dense breasts, cancers are easily masked by dense tissue structures and are therefore not
detectable. In Chapter 5, several masking risk estimators are proposed and tested on the
ability to distinguish false negative from true negative screening mammograms.
In Chapter 6, the screening program performance is evaluated in relation to the compression
pressure applied to the breast during mammogram acquisition. In the analysis, confounding
factors like breast density and multiple screening rounds per woman are considered.
This thesis is concluded by summaries and discussions in English, Dutch and German.
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Abstract
Purpose: To determine to what extent volumetric mammographic density influences screen-
ing performance when using digital mammography.
Methods: We collected a consecutive series of 111,898 digital mammography examina-
tions (2003-2011) from one screening unit of the Dutch biennial screening program (age
50-75 years). Volumetric mammographic density was automatically assessed using Vol-
para. We determined screening performance measures for four density categories compar-
able to the American College of Radiology (ACR) breast density categories.
Results: Of all the examinations, 21.6% were categorised as density category 1 (’almost
entirely fatty’) and 41.5%, 28.9% and 8.0% as category 2 to 4 (’extremely dense’), respect-
ively. We identified 667 screen-detected and 234 interval cancers. Interval cancer rates
were 0.7‰, 1.9‰, 2.9‰ and 4.4‰ and false positive rates were 11.2‰, 15.1‰, 18.2‰
and 23.8‰ for categories 1 to 4, respectively (both p-trend<0.001). The screening sensit-
ivity, calculated as the proportion of screen-detected among the total of screen-detected and
interval tumours, was lower in higher density categories: 85.7%, 77.6%, 69.5% and 61.0%
for categories 1 to 4, respectively (p-trend<0.001).
Conclusions: Volumetric mammographic density, automatically measured on digital mam-
mograms, impacts screening performance measures along the same patterns as established
with ACR breast density categories. Since measuring breast density fully automatically has
much higher reproducibility than visual assessment, this automatic method could help with
implementing density-based supplemental screening.
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2.1 Introduction
Breast density increases breast cancer risk [10, 22]. In addition, sensitivity of screening
mammography is lower for women with dense breasts, caused by the masking effect of
dense (fibroglandular) breast tissue [26, 27]. This has led to breast density legislation in 28
states of the United States of America (USA) until now, and has fuelled ongoing discussions
on the need for supplemental screening for women with dense breasts world-wide [63].
One hoped that screening performance in women with dense breasts would improve when
film-screen mammography was replaced by digital mammography. Unfortunately, screen-
ing sensitivity was still worse in women with dense compared to non-dense breasts when
digital mammography was used [28, 29, 31].
Most large studies looking into the effect of breast density on screening performance used
the Breast Imaging-Reporting and Data System (BI-RADS) for breast density assessment,
which is assessed by radiologists. However, this method has a moderate inter-observer
agreement [40, 42, 64, 65]. With the advent of digital mammography, several fully auto-
matic volumetric density assessment methods have been developed. Volpara is one of these
methods, and has shown correlation with BI-RADS density categories andMRI breast dens-
ity measurements [48–50,53].
The effect of automatically measured volumetric breast density on screening sensitivity has
only been studied once [30]. However, information about the effect of automatically meas-
ured volumetric breast density on other screening performance measures like recall rates,
false positive rates and positive predictive values (PPV) was not reported in this study.
Therefore, the aim of this study was to examine to what extent automatically measured
volumetric mammographic density affected screening sensitivity and other screening per-
formance measures in a large Dutch population-based screening program cohort containing
a consecutive series of digital screening mammograms and complete information about
interval cancers.
2.2 Materials and Methods
2.2.1 Study population
Data were acquired from a breast cancer screening unit (Preventicon screening unit 19,
Utrecht, the Netherlands) of the Foundation of Population Screening Mid-West, one of the
five screening regions of the Dutch breast cancer screening program. Women participating
in this biennial screening program are aged 50 to 75. The program involves mammography
only, and all mammograms are read by two certified screening radiologists. In the Dutch
screening program, previous screening mammograms are most of the time available for
comparison in case of subsequent screens.
In 2003, digital mammography was introduced at the Preventicon screening unit [66–68].
Analogue mammography systems were gradually replaced by digital ones. In July 2007
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almost all mammograms at this screening unit were digital [67].
By participating in the Dutch screening program, women consent to their data being used
for evaluation and improvement of the screening, unless they have indicated otherwise.
2.2.2 Data collection
We prospectively collected all unprocessed digital mammography examinations that were
taken at the Preventicon screening unit between 2003 and 2011, with exception of a 4-month
period in 2009 when only processed data were archived. All mammograms were acquired
using Lorad Selenia systems (Hologic, Danbury, Conn.). The first screening examination of
a woman in the screening program, always included the two standard views, craniocaudal
(CC) and mediolateral oblique (MLO). At subsequent screening examinations, MLO was
the routinely acquired view and CC was acquired in 57% of the cases by indication (e.g.
high breast density, visible abnormality) during the study period. Recall and breast cancer
detection information was obtained from the screening registration system. Interval cancers
were identified through linkage with the Netherlands Cancer Registry.
Examinations were excluded, when information about recall or final outcome was missing.
In addition, examinations for which breast density could not be determined, and interval
cancers diagnosed more than 24 months after the last screening mammogram were ex-
cluded for analysis.
Tumour information such as maximum diameter, nodal status and ICD-O codes were ob-
tained from the screening registration system. Nodes were classified negative when the
sentinel lymph node, or the dissection specimen in case no sentinel lymph node procedure
was performed, contained no or only isolated tumour cells. Nodes were considered positive
if they contained micrometastases (0.2-2mm) or metastases larger than 2mm.
2.2.3 Volumetric mammographic density assessment
Percentage dense volume (PDV) was automatically assessed from unprocessed mammo-
grams of the left and right breasts, andMLO and CC views using the commercially available
Volpara Density software (version 1.5.0, Volpara Solutions, Wellington, New Zealand) [47].
The average PDV per screening examination was determined using the available views of
both breasts. Volpara Density Grades (VDGs) were constructed based on this average PDV
(VDG 1: 0% ≤ PDV < 4.5%, VDG 2: 4.5% ≤ PDV < 7.5%, VDG 3: 7.5% ≤ PDV <
15.5%, VDG 4: PDV  15.5%). The VDGs are designed to mimic the American College
of Radiology BI-RADS breast density categories (4th edition).
2.2.4 Statistical analysis
Examinations were grouped according to VDGs. Within these groups, we determined the
following screening performance measures with accompanying 95% confidence intervals
(CI) using generalized estimating equations to account for correlation between examina-
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tions of the same woman using the ’independence’ correlation structure: recall rate, false
positive rate, screen-detected breast cancer rate, interval breast cancer rate, total breast can-
cer rate (all rates are per 1000 screening examinations), sensitivity, specificity and positive
predictive value (PPV). For the screening sensitivity, we calculated Wilson’s 95% confid-
ence intervals (see Table 2.1 for screening performance definitions). For comparison with
American screening programs, we also determined interval cancer rates for the first year
after a negative screening mammogram, since the screening interval in the USA is nor-
mally 1 year.
We performed several sensitivity analyses: 1) taking only invasive tumours into account
(i.e. excluding the examinations leading to a true positive or false negative diagnosis of in
situ carcinoma); 2) taking only subsequent screening rounds into account, since perform-
ance measures are expected to be different between first and subsequent rounds (in case of
subsequent rounds, the prior mammogram could be analogue or digital); 3) using VDGs
based on the mean PDV of only the MLO views instead of using all available views.
We tested for linear trends across the four density categories for screening performance
measures, the percentage of in situ cancers, and positive lymph nodes with a chi square lin-
ear trend test. In addition, we examined whether tumours diagnosed in dense breasts were
larger than in non-dense breasts, using the Jonckheere-Terpstra test, as we expected tumour
size not to be normally distributed. All statistical tests were two-sided. Statistical analyses
were performed in IBM SPSS statistics, version 21 and in R, version 3.2.2 using the ’geese’
function from the ’geepack’ package.
2.3 Results
In total, 113,956 screening examinations were available. We excluded 50 examinations of
which the screening outcome was unknown, 47 interval cancers which were diagnosed more
than 24 months after the last screening examination, and 1,961 examinations for which
VDG could not be assessed. This resulted in 111,898 examinations belonging to 53,239
women with a median age of 58 years (IQR: 53 - 64 years). Among the examinations,
21.6% were categorised as density category 1 (’almost entirely fatty’), and 41.5%, 28.9%
and 8.0% as category 2 to 4 (’extremely dense’), respectively (Table 2.2). In total, 667
screen-detected breast cancers were identified based on a mammogram taken before Janu-
ary 1, 2012, and 234 interval cancers were identified within 24 months after a mammogram
taken before January 1, 2012, of which 79.5% and 97.9%, respectively were invasive breast
cancers (Table 2.2 and Table 2.3).
2.3.1 Screening performance across volumetric density categories
Table 2.4 shows that total and interval breast cancer rates, recall rates, and false positive
rates were higher in higher breast density categories compared to lower density categor-
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Interval breast cancers also
called false negatives (FN)
Breast cancers diagnosed within 24 months after
a screening examination that did not lead to
recall (negative mammogram), and before the next
scheduled screening examination.
Screen-detected breast cancers
also called true positives (TP)
Breast cancers diagnosed after a recalled screening
examination (positive mammogram).
False positives (FP) Screening examinations that led to a recall (positive
mammogram), but not to a breast cancer diagnosis
within 24 months after the examination, or before the
next scheduled screening examination.
True negatives (TN) Screening examinations that did not lead to recall
(negative mammogram) and no breast cancer was
diagnosed within 24 months after the examination, or
before the next scheduled screening examination.
Sensitivity of screening The number of screen-detected breast cancers divided
by the total number of screen-detected plus interval
breast cancers ((TP/(TP+FN)).
Specificity of screening Number of screening examinations that did not
lead to recall (negative mammogram) and no breast
cancer diagnosis within 24 months, or before the
next scheduled screening examination divided by the
total number of examinations without breast can-
cer diagnosis within 24 months, or before the next
scheduled screening examination ((TN/(TN+FP)).
Positive predictive value (PPV) The number of screen-detected breast cancers divided
by the total number of examinations that led to recall
((TP/(TP+FP)).
Table 2.1: Definitions of screening performance measures.
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ies, all with a significant linear trend (p-trend<0.001). Screen-detected breast cancer rates
were found to be lowest in the lowest breast density category (4.0 per 1000 examinations
(‰)) and more comparable across the three highest breast density categories: 6.4‰, 6.6‰
and 6.8‰, respectively (p-trend<0.001). The screening sensitivity was significantly lower
(p-trend<0.001) in higher breast density categories: 85.7%, 77.6%, 69.5%, 61.0% in VDG
categories 1 to 4, respectively. No significant linear trend was found for PPV (p-trend=0.12)
(Table 2.4).
Overall trends for interval cancer rates, recall rates and false positive rates, screening sensit-
ivity and specificity were similar when either invasive cancers alone or both invasive cancer
and in situ cancers, were taken into account. However, when restricting the analyses to
invasive cancers only, the screening sensitivity in VDG 4 decreased most notably compared
to the screening sensitivity when both in situ and invasive breast cancers were taken into ac-
count. When only subsequent screening rounds were taken into account, the overall trends
were again similar to the analyses based on both first and subsequent screening examina-
tions (Table 2.4).
The results of the sensitivity analysis where PDV was based on MLO views only did not
differ from those based on all available views (data not shown).
In VDG category 1, 25% of the interval breast cancers were diagnosed in the first year after
screening examination; in VDG categories 2 and 3 this was 41% and in VDG category
4 67%. This resulted in interval cancer rates in the first year after a screening examina-
tion of 0.2‰, 0.8‰, 1.2‰, and 2.9‰ (p-trend<0.001) in VDG categories 1, 2, 3, and 4,
respectively.
2.3.2 Tumour characteristics across volumetric density categories
Of all tumours 74.0% were screen-detected and 26.0% were interval cancers. 15.7% of
all tumours were in situ and 84.3% were invasive tumours. 89.4% of the in situ tumours
showed microcalcifications on the last screening mammogram. For screen-detected tu-
mours, the highest proportion of in situ tumours was found in the highest density category
(in VDG 4, 32.8% of the screen-detected tumours were in situ tumours) and the lowest pro-
portion in density category 2 (in VDG 2, 15.8% of the screen-detected tumours were in situ
tumours). A significant linear trend was observed for the proportion of invasive tumours
over breast density categories among screen-detected tumours (p-trend=0.03).
About 80% of the screen-detected and slightly over 50% of the interval invasive breast
cancers were smaller than 20mm (pT1 status) at diagnosis. No linear trend was found for
screen-detected tumour size across the four density categories (p-trendSD=0.10) (Table 2.3).
Lymph nodes were positive in 29.3% of the screen-detected cancers and 36.8% of the inter-
val cancers. For lymph node status, no linear trend was found across the four breast density
categories for screen-detected breast cancers (p-trendSD=0.08) (Table 2.3).
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2.4 Discussion
We found that the sensitivity of a digital mammography screening program was signific-
antly lower in women with high volumetric breast density than in women with low volu-
metric breast density (61.0% and 85.7%, respectively, (p-trend<0.001)). This is despite the
higher recall rates in women with high compared to low breast density (30.7‰ and 15.2‰,
respectively) (p-trend<0.001).
A study of Destounis et al. [30], which was recently published, also studied the screen-
ing sensitivity in four automatically determined volumetric breast density categories. They
found screening sensitivities of 95%, 89%, 83% and 65% in density categories 1 to 4 re-
spectively. Additionally, they determined the mammographic screening sensitivity across
the visual BI-RADS categories and found sensitivities of 82% in the lowest and 66% in the
highest breast density category.
Four other studies where breast density was visually assessed on digital screening mammo-
grams, also found a negative influence of breast density on screening sensitivity [28,29,31,
32], a fifth study [69] did not find this result. A Canadian study [31] showed a lower screen-
ing sensitivity for women with 75% or higher breast density (74.2% (95% CI: 67.2-80.4))
compared to women with less than 75% breast density (80.2% (95% CI:78.4-81.9)) when
using direct radiography in a biennial screening program, where women who are considered
to be at increased risk were screened annually. In the American Digital Mammographic
Imaging Screening Trial (DMIST), the screening sensitivity was determined for women
with dense and non-dense breasts for several subgroups. Sensitivity seemed higher for all
non-dense compared to dense subgroup comparisons, with exception of postmenopausal
women aged 50 to 64 years [28]. In a study using data from the Breast Cancer Surveillance
Consortium (BCSC), Kerlikowske et al. [29] found that in an annual digital mammography
screening program sensitivity was also significantly lower in the higher BI-RADS breast
density categories than in the lower BI-RADS categories for women aged 50 to 74 years.
However, in another paper by Kerlikowske et al. [69], also using BCSC data, no significant
differences in screening sensitivity between breast density categories was found, when di-
gital mammography was used. Finally, in a recently published study of Weigel et al. [32],
where data of the German biennial screening program was used, screening sensitivity was
found to be lower in the higher as compared to the lower breast density categories. In that
study, screening sensitivities of 100% and 50% were found for the lowest and the highest
density category, respectively.
Although the results in the above studies are not completely consistent, the majority of them
showed that screening performance is still negatively influenced by breast density when di-
gital mammography is used instead of film screen mammography. This is also found in the
current study.
Four out of six above-mentioned studies were conducted in the USA [28–30, 69]. The
only European study determining the influence of breast density on digital mammography
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screening performance was the recently published study of Weigel et al. [32]. However,
our study is the first to determine the effect of automatically assessed volumetric mammo-
graphic density on digital mammography screening performance in a European population-
based screening setting. There are three notable differences between European and Amer-
ican screening programs: 1) recall rates are below 5-7% in Europe and around 8-10% in the
USA [69–75]; 2) double reading, which is also used in this study, is common in European
screening programs, but not in the USA [76]; 3) the screening interval is different. Biennial
screening is common in European countries, while in the USA women are mostly screened
yearly [76].
When looking at the interval cancers diagnosed within the first year after a negative screen-
ing mammogram, we found that in the lower density categories only a small part of the
interval cancers were found in the first year after a negative screening examination, and
most were found in the second year, whereas in women with extremely dense breasts, this
was the other way around. Although a one year screening interval instead of a 2 year screen-
ing interval would probably result in a higher program sensitivity in all density groups, this
will happen to a larger extent in the women with fatty breasts than in those with extremely
dense breasts, resulting in larger differences in screening sensitivity across density categor-
ies.
When only invasive cancers instead of both invasive and in situ cancers were taken into
account, the screening sensitivity decreased most notably in VDG 4. This indicates that the
detection of invasive breast cancers in digital mammography screening is hampered to a
larger extent than the detection of in situ breast cancers (Table 2.4). A possible explanation
for this is that the visibility of microcalcifications, that often are the hallmark of ductal car-
cinoma in situ (DCIS) on mammography [68], is not hampered as much in dense tissue as
the visibility of invasive breast cancers. 89.4% of the DCIS in our study was accompanied
by microcalcifications.
False positive rates were found to be higher in women with dense breasts compared to
women with non-dense breasts. Similar trends were found in two American studies using
BCSC data [29, 77].
When looking at the tumour characteristics of screen-detected breast cancers, we observe a
significant linear trend for the proportion of invasive tumours over breast density categories
(p-trend=0.03). In addition, the size of screen-detected cancers, and the proportion of pos-
itive lymph node status among screen-detected cancers seem to be larger in denser breasts.
However, no significant linear trend was found for screen-detected tumour size and posit-
ive lymph node status proportion across the four density categories (p-trend size=0.10 &
p-trend lymph node status=0.08).
It should be noted that the four density categories (VDGs) used in this study are compar-
able to the 4th edition BI-RADS density categories. Although in 2013 the 5th BI-RADS
density edition was introduced, we here still used the VDG categories comparable to the
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4th edition, to enable better comparison with previous studies.
A limitation of this study is that during the study period the MLO view was the standardly
acquired view for the subsequent screening rounds and CC views were only taken in addi-
tion to MLO during the first screening round or by indication during subsequent rounds. As
a result, breast density was determined based on only MLO views for some examinations
and on both MLO and CC views for other examinations in our main analysis. Volpara’s
PDV measured on CC views tends to be somewhat higher than on MLO views [24]. As CC
views are more often performed among women with dense breasts and women with a suspi-
cious region on their MLO view, breast density might be somewhat artificially elevated for
these women. Our sensitivity analysis using VDG categories based on PDV from the MLO
views only did not lead to different conclusions. Screening sensitivity is presumably higher
when both MLO and CC views are available compared to MLO views only. Therefore,
standardly taking both MLO and CC views would lead to higher sensitivity, particularly in
women with fatty breasts as they are the ones who most often receive MLO views only.
This would lead to larger differences in screening performance across breast density cat-
egories.
Strengths of this study are the large sample size and the fact that the digital mammograms
were acquired in routine screening. In addition, we used a fully automatic method to de-
termine PDV, which was possible because unprocessed image data were archived. In sev-
eral studies, this automatic method (Volpara) showed to be correlated with BI-RADS breast
density and to give comparable breast cancer risk estimations as with BI-RADS breast dens-
ity [48–50]. In addition, it has been validated against MRI [53]. Volpara gives objective and
reproducible density measurements, representing the amount of dense tissue rather than the
size of the dense tissue projection as measured by area-based methods.
In summary, in a large screening population, where digital mammography was used for
screening and a fully automatic method (Volpara) was used to determine PDV, breast dens-
ity was found to significantly hamper the detection of breast tumours. This is shown by a
lower screening sensitivity in women with dense compared to those with non-dense breasts,
which existed despite a higher recall rate for women with dense breasts. These findings
are in line with results of most studies using visually assessed BI-RADS density on di-
gital mammograms. Since measuring breast density fully automatically has higher repro-
ducibility than visual assessment, this automatic method could help with facilitating a more
tailored screening, such as supplemental screening for women with dense breasts.
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Abstract
Reliable breast density measurement is needed to personalise screening by using density
as a risk factor and offering supplemental screening to women with dense breasts. We in-
vestigated the categorisation of pairs of subsequent screening mammograms into density
classes by human readers and by an automated system.
With software (VDG) and by four readers, including three specialised breast radiologists,
1000 mammograms belonging to 500 pairs of subsequent screening exams were categorised
into either two or four density classes. We calculated percent agreement and the percentage
of women that changed from dense to non-dense and vice versa. Inter-exam agreement
(IEA) was calculated with kappa statistics. Results were computed for each reader indi-
vidually and for the case that each mammogram was classified by one of the four readers
by random assignment (group reading).
Higher percent agreement was found with VDG (90.4%, 95% CI 87.9-92.9%) than with
readers (86.2-89.2%), while less plausible changes from non-dense to dense occur less of-
ten with VDG (2.8%, 95% CI 1.4-4.2%) than with group reading (4.2%, 95%CI 2.4-6.0%).
We found an IEA of 0.68-0.77 for the readers using two classes and an IEA of 0.76-0.82
using four classes. IEA is significantly higher with VDG compared to group reading.
The categorisation of serial mammograms in density classes is more consistent with auto-
mated software than with a mixed group of human readers. When using breast density to
personalise screening protocols, assessment with software may be preferred over assess-
ment by radiologists.
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3.1 Introduction
The association between breast density and breast cancer risk is well established. Several
studies show that the risk of developing breast cancer is two to six times higher for wo-
men with dense breasts than for women in the lowest density category [10,22–24]. Though
studies suggest that with the introduction of digital mammography differences in sensitiv-
ity across density categories disappear [69], sensitivity of mammography is still impaired
by density, because dense tissue can mask cancers [29, 31]. Therefore, personalised breast
cancer screening protocols involving ultrasound and MRI are developed taking into account
breast density [34].
The most common breast density reporting method is the Breast Imaging Reporting and
Data System (BI-RADS) [37] which uses four categories. Studies have shown a consider-
able inter- and intra-reader variability when using BI-RADS [39–42].
To overcome these variabilities, semi and fully automatic methods were developed to quan-
tify breast density. A first approach was the area based method Cumulus [55]. With Cu-
mulus, the radiologist has to set a threshold to distinguish fibroglandular tissue from fatty
tissue. Subsequently, the proportion fibroglandular tissue is calculated with respect to the
breast area. BI-RADS and Cumulus are limited by the fact that they are based on the two-
dimensional projection of fibroglandular tissue. This projection varies with the projection
angle and threshold settings and ignores the three-dimensional anatomical breast structure.
To overcome these limitations, quantitative image analysis methods were developed based
on imaging physics [45–47, 78, 79]. These methods take the thickness of the compressed
breast and imaging parameters into account to measure the absolute (cubic centimetres) and
relative (percentage of the breast volume) amount of fibroglandular tissue.
Development of automated breast density assessment methods is an important step towards
the introduction of personalised screening protocols adjusted to the need of individual wo-
men. This includes supplemental screening to mammography or the replacement of mam-
mography with MRI or ultrasound. To be accepted in practice, it is important to have
a consistent, objective and reproducible measurement of breast density to stratify women
unambiguously in non-dense and dense categories. With a poor density measurement clini-
cians and women may lose confidence in the stratification process. Therefore, the temporal
aspect of density measurements is very important, as it may be hard to explain why sup-
plemental screening is offered in an irregular pattern. This is acknowledged in a recent
review paper, where concerns are raised that radiologists‘ variability of BI-RADS density
assessments over time may lead to inconsistent information in mandated communications
about elevated breast cancer risk and supplemental screening [62].
Changes in density classes over time can be caused by changes in hormonal status or a
change of BMI. It is known that density usually decreases gradually with lifetime [25], so
a change to a lower category is expected for some women. The reproducibility of auto-
mated volumetric breast density measurements was studied with repeated exams [80, 81].
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In these studies no significant differences in density measurements were observed. Fur-
thermore, several studies found good correlations between automated and human density
assessment [49, 50, 64].
The purpose of this study is to investigate the consistency of density classifications in serial
screening mammograms with fully automated volumetric density measurements and to
compare these results to classifications of human readers, operating individually or as a
group with mammograms distributed randomly over the readers. The latter does better re-
flect screening practice as serial mammograms are usually not read by the same radiologist.
3.2 Materials and Methods
3.2.1 Materials
Digital Mammograms from the Dutch breast cancer screening program were used which
were acquired in a population of 56,000 women between 2003 and 2012. In this program,
women aged 50-75 receive a biennial invitation for breast cancer screening. All mammo-
grams were recorded with Lorad Selenia systems (Hologic, Bedford, USA). Consecutive
exam pairs were selected in which we call the oldest exam the prior and the more recent
exam the current. All mammograms were processed with Volpara (v1.5.0, Volpara Health
Technologies, Wellington, New Zealand) to obtain breast density scores. For this purpose
we used the ’for processing’ (raw) data. In total, there were 67,260 pairs and for 64,308
pairs density computation was successful. Missing values were due to breast implants
(1.3%) and software failures (3.1%). For this study, we randomly selected 500 women,
where for every woman one pair with a prior and current exam was selected at random.
The average screening interval in the 500 pairs was 30 months and is more than 24 months,
because sometimes women skip screening. A screening interval of 26 months was meas-
ured most frequently, which corresponds to the median screening interval. The mean age
was 58.8±6.7 years at the prior screening.
Not all mammograms in our study had four views, because until recently four-view mam-
mography was not standard in the Dutch screening program. Instead, four views were taken
in the first screening round and in subsequent rounds only mediallateral oblique (MLO) im-
ages were acquired unless there was an indication for additional cranialcaudal (CC) images,
like high breast density or a possible abnormality judged by the radiographer. Of the 1000
exams used, 415 exams had MLO views only, while 585 exams had MLO and CC views.
For 473 exams, only ’for processing’ images were available. To enable density assessment
by the radiologists these exams were converted to ’for presentation’ format using dedicated
software (called ’in-house’ processing through this paper). It was verified that the present-
ation quality of these images was appropriate for density assessment.
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3.2.2 Experimental design
For all images, volumetric percent density was calculated with Volpara by dividing the
fibroglandular tissue volume by the breast volume. Volpara uses quantitative image analysis
algorithms based on physical models [45–47]. We averaged all available percent density
estimations of an exam. Using the averaged percent density estimate, we categorised all
exams using the Volpara density grade (VDG) [82], which is a four point scale matched to
the BI-RADS categories. Additionally, we categorised studies with a VDG of one or two
as non-dense while we labelled studies with VDG of three or four as dense.
Three radiologists (R1, R2 and R3) with more than eight years of experience in breast ima-
ging and a PhD student (R4) with a medical degree and two years of experience with breast
imaging assigned BI-RADS scores (4th edition) individually to each exam. The radiolo-
gists were familiar with the density categories, as these are routinely assessed in clinical
practice. We categorised studies with a score of one or two as non-dense while studies with
a score of three or four were categorised as dense.
Each reader performed the BI-RADS scoring in two reading sessions with at least one week
between the sessions. In each of the sessions, 500 exams were scored, including either the
prior or the current mammogram of a pair. Each of these sessions contained 250 prior and
250 current exams. In screening practice current and prior mammograms are often read by
different radiologists. Therefore, we also constructed a ’group reading’, abbreviated with
RG, by assigning the score of a randomly chosen reader to each exam.
We organised two additional reading sessions to study the intra-reader variability and the
effect of processing. An overview of these third and fourth reading sessions is shown in
Figure 3.1. We selected 50 exams with ’in-house’ processing and 50 exams with the ori-
ginal processing from the 1000 exams read in the first two sessions. These 100 exams
were chosen randomly, though with the same VDG distributions as the 1000 exams. The
selected exams were equally distributed over the two sets presented in the third and fourth
reading session. Additionally, the 50 exams that were read in the first sessions with ori-
ginal processing were duplicated in the series to be read, but now with in-house processing.
The exams were distributed over the reading sessions as well, where we took care that the
original and the in-house processing of an exam were not presented in the same session.
Thus, 75 exams were scored in each session. This experimental setting allows us to assess
the intra-reader agreement by comparing the density scores given in the two additional ses-
sions to the density scores given in first two reading sessions. Secondly, we can compare
the density score given based on the reading with in-house processing to the density score
given based on images presented with original processing (Figure 3.2).
3.2.3 Statistical methods
The percentage of women categorised in the same class for the prior and current exam and
the percentage of women that change from the non-dense to the dense category and vice
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Figure 3.1: An overview of the procedure to study the intra-reader variability and the effect of
processing.
Figure 3.2: An overview about the possible intra-reader agreement calculations. For the 50 images
that were read in session 1 and 2 with original processing, three different intra-reader agreements
calculations are possible. For the image that were initially read with in-house processing, only one
intra-reader agreement was determined.
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versa were calculated using the results of the first two reading sessions. We used bootstrap-
ping to calculate the 95% confidence interval (CI) of these percentages and to determine if
there are significant differences between VDG and results of each reader.
The inter-exam agreement was calculated with Cohen’s weighted kappa, using either two
or four density classes. Moreover, we determined the average kappa value of the readers.
To compare the kappa value of the group reader and VDG we used bootstrapping [83]. We
also calculated the agreement for a subset of cases in which women who skipped a screen-
ing round were excluded. We selected this subset by including only cases for which the
screening interval between the exams was within 20-28 months.
For comparison with other studies in the literature, intraclass correlation coefficients (ICCs)
were calculated to examine the inter-exam agreement of the four classes categorisation.
Additionally, the inter-reader agreement was determined using kappa statistics and the
scores assigned to the 1000 exams of the first two reading sessions.
Intra-reader agreements for different reading conditions, depending on processing type,
were determined with Cohen’s weighted kappa, taking into account two or four density
classes. Figure 3.2 gives an overview of the comparisons we made. First, for the images
that were presented with in-house processing the intra-reader agreement (IRAa) between
scores in the first two sessions and those in the third and fourth sessions was calculated.
Second, the same was done for the 50 exams that were presented with original processing
in these sessions (IRAb). Third, we determined intra-reader agreement for the condition
that processing types were different, by comparing the scores of the 50 cases with original
processing in the first two sessions that were presented again, but with in-house processing,
in the additional session (IRAc). Fourth, we determined intra-reader agreement for the
mixed processing condition using the exams presented twice, once with in-house and once
with original processing, in the additional reading sessions (IRAd). All four kappa values
were compared to each other including correction for multiple testing (Bonferroni).
We used the kappa definition of Landis and Koch [84], with the following interpretation:
values<0 poor agreement; 0.00-0.20 slight agreement; 0.21-0.40 fair agreement; 0.41-0.60
moderate agreement; 0.61-0.80 substantial agreement; and 0.81-1.00 represent almost per-
fect agreement. The statistical analysis was performed using the statistical software package
R (v3.1.1, R Foundation for Statistical Computing, Vienna, Austria). Starting point of our
analysis was a script of Vanbelle [85].
3.3 Results
3.3.1 Inter-exam agreement
Breast density assessments are compared by looking at changes of the scores between prior
and current exams (500 pairs). In Table 3.1 we show changes using the two category classi-
fication of dense and non-dense mammograms and the percentage of cases without change
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including 95% confidence intervals. VDG has the highest percentage of cases without
change, 90.4% (CI 87.9-92.9%) compared to 86.2-89.2% for the readers, which is signific-
antly higher than reader 3 and the group reading. The percentage of cases with a change
from non-dense to dense was 2.8% (CI 1.4-4.2%) using VDG, which was lower than the
4.2% (CI 2.4-6.0%) obtained with group reading. Reader 4 had the same result as VDG
and only reader 1 had a lower score. The percentage of women in which a category change
from dense to non-dense was observed ranged from 6.6% to 10.4%.
non-dense prior dense prior and no category change
and dense current non-dense current
VDG 2.8 (1.4-4.2) - 6.8 (4.6-9.0) - 90.4 (87.9-92.9) -
R1 1.4 (0.4-2.4) 0.077 9.7 (7.0-12.4) 0.067 89.0 (86.3-91.7) 0.379
R2 5.2 (3.2-7.2) 0.043 6.6 (4.4-8.8) 0.860 88.2 (85.5-90.9) 0.204
R3 3.4 (1.8-5.0) 0.589 10.4 (7.7-13.1) 0.030 86.2 (83.1-89.3) 0.029
R4 2.8 (1.4-4.2) 0.986 8.0 (5.6-10.4) 0.396 89.2 (86.5-91.9) 0.456
RG 4.2 (2.4-6.0) 0.222 9.1 (6.6-11.6) 0.157 86.8 (83.9-89.7) 0.038
Table 3.1: Mean percentage pairs with a category change from non-dense to dense, dense to non-
dense and mean percentage pairs that got twice the same density score (using two categories) of the
500 pairs. The 95% CI is given in brackets and the p-value for the comparison between VDG and
the individual readers (R1-R4), and between VDG and the group reading (RG) given as well.
Consistency of breast density in serial mammograms was also evaluated by calculating
kappa values. The agreement is given in Table 3.2 column (a). The agreement was substan-
tial for the readers with values ranging from 0.76-0.82 and 0.68-0.77 using four and two
classes, respectively. Using VDG we obtained a kappa of 0.85 (CI 0.82-0.87) and 0.80 (CI
0.74-0.85) for four and two classes, respectively. The kappa value is significantly higher
with VDG than with group reading (p<0.001 and p=0.010 for four and two classes).
Table 3.2 also shows the agreement for a subset of 373 women (screening interval 20-
28 months). The agreement is slightly higher on average, because women who skipped a
screening were excluded in this subset. These women are expected to have a larger decrease
in breast density caused by normal involution.
The ICC (95% CI) of the scores for the prior and current exams was 0.91 (0.89-0.92), 0.79
(0.75-0.82), 0.77 (0.73-0.81), 0.76 (0.72-0.79), 0.82 (0.79-0.84), and 0.75 (0.71-0.78) for
VDG, R1, R2, R3, R4 and RG, respectively. The contingency tables of VDG and the reader
scores of prior and current exams are shown in Table 3.4.
3.3.2 Inter-reader agreement
With the scores of the 1000 exams presented in the two sessions the inter-reader agreement
was calculated. We found a substantial to almost perfect agreement, with kappa values
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between 0.78 and 0.83 using four categories. The agreement for two categories is between
0.73 and 0.78. The agreement between the readers and VDG is lower. We observed kappa
values between 0.73 and 0.78, and 0.63 and 0.71 using four and two categories, respectively.
In most of the pairs with a disagreement between VDG and the reader, a higher score was
given by the software than by the reader. The individual inter-reader agreements are given
in Table 3.3.
A) four categories B) two categories
a b a b
VDG 0.85 0.87 VDG 0.80 0.83
R1 0.79 0.80 R1 0.76 0.77
R2 0.77 0.77 R2 0.70 0.69
R3 0.76 0.77 R3 0.68 0.70
R4 0.82 0.82 R4 0.77 0.78
RG 0.77 0.78 RG 0.70 0.72
average reader 0.79 0.79 average reader 0.73 0.74
Table 3.2: Mean inter-exam agreement kappa, based on four (A) and two (B) categories, using (a)
all pairs (N=500), and (b) pairs with a screening interval of 20-28 months (N=373). Next to the
individual readers we give the average kappa value and the kappa for VDG.
VDG R1 R2 R3 R4
VDG 0.70 0.63 0.65 0.71
R1 0.78 0.73 0.77 0.78
R2 0.73 0.78 0.74 0.74
R3 0.76 0.79 0.78 0.74
R4 0.77 0.83 0.78 0.80
Table 3.3: Inter-reader agreement kappa, based on two (normal font) and four categories (bold font).
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current assessment VDG
prior assessment VDG 1 2 3 4
1 85 (17.0) 9 (1.8) 0 (0.0) 0 (0.0)
2 53 (10.6) 135 (27.0) 14 (2.8) 0 (0.0)
3 0 (0.0) 34 (6.8) 120 (24.0) 6 (1.2)
4 0 (0.0) 0 (0.0) 10 (2.0) 34 (6.8)
current assessment R1
prior assessment R1 1 2 3 4
1 103 (20.6) 17 (3.4) 0 (0.0) 0 (0.0)
2 62 (12.4) 123 (24.6) 7 (1.4) 0 (0.0)
3 1 (0.2) 46 (9.2) 115 (23.0) 6 (1.2)
4 1 (0.2) 0 (0.0) 5 (1.0) 14 (2.8)
current assessment R2
prior assessment R2 1 2 3 4
1 60 (12.0) 13 (2.6) 0 (0.0) 0 (0.0)
2 33 (6.6) 231 (46.2) 26 (5.2) 0 (0.0)
3 1 (0.2) 32 (6.4) 76 (15.2) 11 (2.2)
4 0 (0.0) 0 (0.0) 4 (0.8) 13 (2.6)
current assessment R3
prior assessment R3 1 2 3 4
1 68 (13.6) 21 (4.2) 0 (0.0) 1 (0.2)
2 63 (12.6) 154 (30.8) 16 (3.2) 0 (0.0)
3 0 (0.0) 51 (10.2) 64 (12.8) 10 (2.0)
4 0 (0.0) 1 (0.2) 17 (3.4) 34 (6.8)
current assessment R4
prior assessment R4 1 2 3 4
1 97 (19.4) 27 (5.4) 0 (0.0) 0 (0.0)
2 35 (7.0) 134 (26.8) 14 (2.8) 0 (0.0)
3 1 (0.2) 39 (7.8) 93 (18.6) 17 (3.4)
4 0 (0.0) 0 (0.0) 18 (3.6) 25 (5.0)
Table 3.4: Contingency tables of breast density at prior and current screening of the Volpara density
grade (VDG) and the four readers. Given is the number of pairs and the percentage.
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3.3.3 Intra-reader agreement and the effect of processing
The intra-reader agreement was calculated based on 50 exams for each processing (IRAa
and IRAb). For two readers the breast density score was more consistent when images
were read twice with the original processing, while two readers had a higher agreement
for images presented with in-house processing. The kappa values are given in Table 3.5.
Also kappa values for the 50 exams that were read with mixed processing, in session 1
or 2 with original processing and in session 3 or 4 with in-house processing, are shown
in Table 3.5. When comparing the four agreements of each reader with each other, no
significant differences were found.
A) four categories B) two categories
IRAa IRAb IRAc IRAd IRAa IRAb IRAc IRAd
R1 0.72 0.73 0.82 0.74 R1 0.70 0.64 0.69 0.65
R2 0.87 0.84 0.72 0.77 R2 0.77 0.81 0.58 0.64
R3 0.82 0.77 0.84 0.80 R3 0.63 0.71 0.76 0.62
R4 0.86 0.90 0.84 0.83 R4 0.84 0.86 0.77 0.82
Table 3.5: Intra-reader agreement kappa, based on 50 exams in each category, see Figure 3.2. IRAa
is based on in-house processing and IRAb is based on only original processing. For the combination
of both processings (once read with original processing and once read with in-house processing)
IRAc and IRAd are displayed. The agreements for four categories (A) and two categories (B) are
determined.
3.4 Discussion
In this study, we compared the consistency of breast density assessment in serial screening
mammograms obtained with the fully automated volumetric density measurements of Vol-
para to the consistency of human readers who used the BI-RADS categories. We made the
comparison between human readers and automated classification using two categorisations.
We first used a four point scale, as there are four BI-RADS and VDG classes. Additionally,
we grouped the classes into a non-dense and a dense category. The latter may be more
relevant in practice when density measurements are used to determine whether or not the
mammography exam is sufficient for an individual woman and if supplemental screening
should be offered.
We found that more women stay in the same category over time when the classification
was done with VDG than with the simulated group reading (p-value 0.038) which best rep-
resents screening practice. Using two classes, VDG gave the same score to both exams in
90.4% of the cases. An agreement between 86.2% and 89.2% was found for the human
readers. Furthermore, we found that the kappa value was significantly higher with VDG
compared to the kappa value of the group reading (p<0.001 and p=0.010 for two and four
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classes). As the automated density measurement gives more consistent results, especially
when compared to the simulated group reading, this method may be preferred over human
readers for breast density assessment.
We assume that breast density categories assigned to current and prior exams of the same
woman should generally be similar. However, some differences are expected, because there
is a gradual decrease in density with an increase of lifetime [25]. Therefore, we expect
to observe some women changing from a higher to a lower density category, while an in-
crease in density should occur less often. Our data confirmed this expectation. Deviations
from the normal pattern may occur due to weight loss or the use of hormone replacement
therapy (HRT), which may increase density. It should be noted, however, that HRT is not
frequently used in the Netherlands [86]. In 2004, 3.39% of the women aged 40-74 made use
of HRT. As the causes for an increase of density in postmenopausal women are limited, we
see measurement variations as the main cause for a category change into a denser category.
The breast density assessment of the current mammogram was independent of the assess-
ment of the prior exam. This may not reflect future screening practice. When density is
used for stratification in screening, radiologists will know the density score given to the
prior exam. This knowledge may influence the assessment of the current exam, leading
to a higher agreement between the two density assessments. In this way, only significant
changes will lead to a change in density category. Such a strategy can be implemented using
automated scores as well.
To compute volumetric density, both the absolute fibroglandular tissue volume and breast
volume are calculated. Additional comparisons of fibroglandular tissue volume and breast
volume could be used to judge whether a category change was caused by a strong change
of fibroglandular tissue volume or by a change of breast volume caused by weight loss or
gain. With VDG both parameters can contribute to a category change from non-dense to
dense [87]. Other than with VDG, stratification into different screening regimes could be
done with fibroglandular tissue volume directly or with a combination of fibroglandular tis-
sue volume and percent density.
Next to the inter-exam agreement, we measured the inter-reader agreement. The kappa val-
ues found were comparable to the values found in literature [40, 41]. This confirms that an
inter-reader variability regarding the BI-RADS categories exists. Furthermore, we found a
higher agreement between readers than between readers and Volpara. This finding might
suggest that the readers capture masking and breast density in a different way than the soft-
ware and that the software might miss some of the masking and risk associations. The study
of Eng [24] however showed, that both BI-RADS and Volpara correlated with breast cancer
risk, and that the association was stronger for Volpara than for BI-RADS.
To obtain the VDG categories, percent density was averaged over all possible images of
an exam. Therefore, the variance on the percent density measurement might be smaller
with MLO and CC views, compared to exams with only MLO views. However, volumetric
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breast density estimates in the CC views are usually somewhat higher than the estimates
based on MLO views [88], because the breast volume imaged in CC views is generally
smaller. Taking the CC views into account could therefore lead to a slightly higher aver-
age percent density estimate and occasionally to a higher density category. As both human
readers and the computer work with the same data, we do not believe that the limited avail-
ability of CC views has affected our results.
A potential limiting factor in our study is that the mammograms were presented to the read-
ers with different types of processing. Therefore, we investigated if there were systematic
effects on density classification related to processing. We compared the intra-reader agree-
ment on images that were read with different types of processing and found that there was
no significant difference. Therefore, we conclude that the type of processing plays only a
minor role. It is remarked that in screening practice exams may be acquired with systems
from different vendors, which means that different processing methods will occur also in
practice.
Variations in breast density categories in serial screening mammograms have previously
been studied by Spayne [89], Harvey [90] and Singh [91], see also Table 3.6. Spayne
made use of film mammograms (screening interval 3-24 months) and found agreement in
BI-RADS categories in 77.2% and 87.4% of their cases using four and two classes, re-
spectively. In the study by Harvey an agreement of 69.8% and 83.54% was found for
digital mammography, respectively. Categories were assigned in clinical practice and in
only 19.8% of the pairs both exams were scored by the same radiologist. A higher percent
agreement for the majority of readers was found in our study, using two categories, where
digital mammograms were used. Singh studied the inter-exam agreement with three readers
and another automated software system for volumetric breast density measurement (Quan-
tra, Hologic, Bedford, USA) by calculating intraclass correlation coefficients. The results
are comparable to the results found in this study, even though different study populations
were used. The median interval between the two exams of the 144 pairs used by Singh was
13.2 months and is therefore much smaller than the interval used in this study. As there
was less time between the exams than in our study, it is likely that in Singh’s study density
changes were smaller. Furthermore, in that study all prior and current mammograms were
read sequentially with an interval of four weeks, while we randomised the order of priors
and currents and had a minimum interval of only one week. However, we do not think
that the short period between the readings used in our study led to an increased agreement
due to a memory effect. Readers rapidly reviewed the cases and it is unlikely that they did
remember their scores. On the other hand, it may well be that variability of their criteria
for the categorisation increases with the interval length, which would cause a decrease of
agreement over time. In that regard, in screening practice the reader agreement might be
lower than we found, because the screening interval is in reality much longer than the in-
terval in our experiment.
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To conclude, with automated volumetric breast density measurements a more consistent
density assessment of serial screening mammograms was observed than with the density
assessment performed by trained clinicians. The use of volumetric breast density soft-
ware led to a significantly higher consistency than the group reading, where mammograms
were distributed randomly over the readers to mimic screening practice. Given the high
consistency and the lack of potential inter- and intra-reader variability, automated density
assessment may be preferred for breast density stratified screening.
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Abstract
Fibroglandular tissue volume and percent density can be estimated in unprocessed mam-
mograms using a physics-based method, which relies on an internal reference value repres-
enting the projection of fat only. However, pixels representing fat only may not be present
in dense breasts, causing an underestimation of density measurements. In this work, we
investigate alternative approaches for obtaining a tissue reference value to improve density
estimations, particularly in dense breasts.
Two of three investigated reference values (F1,F2) are percentiles of the pixel value dis-
tribution in the breast interior (the contact area of breast and compression paddle). F1 is
determined in a small breast interior, which minimises the risk that peripheral pixels are
included in the measurement at the cost of increasing the chance that no proper reference
can be found. F2 is obtained using a larger breast interior. The new approach which is
developed for very dense breasts does not require the presence of a fatty tissue region. As
reference region we select the densest region in the mammogram and assume that this rep-
resents a projection of entirely dense tissue embedded between the subcutaneous fatty tissue
layers. By measuring the thickness of the fat layers a reference (F3) can be computed. To
obtain accurate breast density estimates irrespective of breast composition we investigated
a combination of the results of the three reference values. We collected 202 pairs of MRI’s
and digital mammograms from 119 women. We compared the percent dense volume estim-
ates based on both modalities and calculated Pearson’s correlation coefficients.
With the references F1− F3 we found, respectively, a correlation of R=0.80, R=0.89
and R=0.74. Best results were obtained with the combination of the density estimations
(R=0.90).
Results show that better volumetric density estimates can be obtained with the hybrid
method, in particular for dense breasts, when algorithms are combined to obtain a fatty
tissue reference value depending on breast composition.
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4.1 Introduction
Mammographic breast density has been identified as an important risk factor for developing
breast cancer [10,22,24]. Eng et al. [24] showed that the breast cancer risk is highly correl-
ated to automated breast density measurements. Breast density was assessed in four density
categories, and the breast cancer risk was up to 8.26 times higher for women with dense
breasts (category 4) compared to women with non-dense breasts (category 1). Furthermore,
it has been shown that sensitivity of mammography decreases with an increase of breast
density [26, 27, 29, 31, 92]. Low sensitivity of mammography in women with dense breasts
is explained by the fact that a tumour can be masked by the presence of fibroglandular tis-
sue (also referred to as dense tissue), which is a combination of connective tissue structures
and epithelial tissue. Fibroglandular and cancerous tissues have a similar attenuation for
X-rays, and thus appear equally white in the mammogram while fatty tissue appears almost
transparent.
Breast cancer screening programs are established in many countries. Starting at an age
of 40-50 years, these programs offer women periodical breast cancer screening exams
with mammography. Personalised breast cancer screening depending on familial risk and
breast density, involving other modalities such as ultrasound or MRI, is under discus-
sion [33, 34, 93]. Screening with MRI is already recommended for women with a lifetime
risk of more than 20-25% [94, 95]. To implement personalised screening based on density,
accurate and objective methods to estimate breast density need to be available.
Different methods have been developed to estimate the amount of fibroglandular tissue in
the breast. An overview of automatic mammographic density segmentation techniques has
been published recently [54]. The methods can be categorised in two types: area-based and
volume-based methods. Area-based methods [55,96–98] were developed to objectively re-
produce the density categories described in the Breast Imaging Reporting and Data System
(BI-RADS) [37]. The BI-RADS density grade is a four-point scale used by radiologists to
estimate the percentage area of fibroglandular tissue that is projected in the mammogram.
A major limitation of area-based methods is that the 3D structure of the breast is not taken
into account as only the projection of fibroglandular tissue is represented. Therefore, the
resulting percentage dense area is not invariant to compression and projection angle. Some
area based methods also have the disadvantage that human interaction is required [55].
To overcome these problems, several methods have been proposed to fully automatically
estimate volumetric percent density, defined as fibroglandular tissue volume divided by
breast volume, on digital mammograms (DM) [45–47, 78, 79, 99]. These methods employ
a physics based model of the X-ray image acquisition process and assume that the breast is
composed of two types of tissue: fat and fibroglandular tissue. Eng et al. have shown that
these breast density estimations correlate well with each other and with breast cancer risk.
One of the algorithms used by Eng et al. is Volpara (Volpara Health Technologies, Welling-
ton, New Zealand) which is based on the work of Highnam [45,47] and van Engeland [46].
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The methods described in Highnam and van Engeland make use of an internal calibration
with a pixel that ideally belongs to the projection of fat only. Only pixels in the breast
interior are taken into account when estimating the internal reference value, where the in-
terior is defined as the region where the breast is in contact with the compression paddle,
excluding the peripheral region of the mammogram in which the breast thickness is smaller.
An important limitation of this calibration approach is that the pixel value used as reference
may not be representative for only fatty tissue in the breast interior if the breast is very
dense. This leads to an underestimation of the fibroglandular tissue volume and percent
density in dense breasts [51–53].
The aim of our study is to improve breast density estimation in very dense breasts and to
find an approach that gives reliable breast density estimations in all types of breasts. We
compared the use of alternative methods for obtaining a fatty tissue reference value. For
that purpose, we estimated the fibroglandular tissue volume and percent density with three
different reference values on mammography and we compared these estimates to reference
breast density estimations obtained fromMRI data. We first used a reference value obtained
with a small breast interior to avoid that pixels of the periphery are accidentally included.
The second method used an enlarged breast interior, which is more likely to include a pixel
value that represents the projection of only fatty tissue, but has a larger risk to overestimate
the reference value due to inclusion of pixels of the peripheral zone. The third approach is
based on the idea that also pixel values representing the largest proportion of fibroglandu-
lar tissue may serve as a reference. By estimating the amount of fibroglandular tissue that
corresponds to the densest part in the mammogram e.g. the difference between the breast
thickness and the amount of subcutaneous fat, the fatty tissue reference value is computed.
The aim of the latter method is to deal with very dense breasts. Obviously, this method
will fail when the breast is not very dense. To overcome this drawback, we investigated if a
combination of the three breast density measurements can lead to an overall improvement
of breast density estimation results.
4.2 Methods
4.2.1 Preprocessing
All mammograms underwent some steps of preprocessing. First the images were segmented
into breast tissue, pectoral muscle (in case of a mediolateral oblique - MLO view) and
background [100]. Additionally, we performed a thickness correction of the peripheral
region. We also determined the Euclidean distance d(r) from each pixel location to the skin-
line in the mammographic projection. The distance d(r) is used several times throughout
the paper and is needed to define the breast interior.
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4.2.2 Fibroglandular tissue volume
As described in van Engeland et al. [46], the volume of fibroglandular tissue can be com-
puted from unprocessed (raw) digital mammograms based on a physical model of image
acquisition and on the assumption that the breast is composed of two types of tissue: dense
tissue and fatty tissue. The dense tissue thickness hd at each pixel location can be calculated
with the following formula:
hd(r) =− 1µd,eff−µf,eff ln
(
g(r)
F
)
(4.1)
where, g(r) is the pixel value at position r and F is the pixel value in a fatty tissue reference
region where hd is supposed to be zero. The effective attenuation coefficients, µf,eff and
µd,eff for fatty and dense tissue, respectively, vary with the breast thickness and with the
anode / filter combination of the X-ray tube and are described in van Engeland et al.. The
total dense tissue volume (VDT ) is given by the integral over the projected breast area B:
VDT =
∫
B
hd(r)d2r =− 1µd,eff−µf,eff
∫
B
ln
(
g(r)
F
)
d2r (4.2)
4.2.3 Fatty tissue reference value
In this work, we studied three approaches to obtain an estimate for the pixel value that
corresponds to the projection of fatty tissue only. Two reference values (F1 and F2) are
based on the pixel value distribution in the breast interior and the third reference value (F3)
was calculated by estimating the proportion of dense tissue in the densest location in the
breast. Each approach is explained in the following section.
Reference value F1 - the maximum pixel value in a small breast interior region
To obtain the reference value F1, we used the same approach as described in van Engeland
et al. The pixel value representative for fatty tissue is determined by taking a large quantile
(0.99) of the pixel value histogram computed in the breast interior. We used this approach
instead of taking the maximum pixel value, because large pixel values may appear in the
mammogram due to artefacts or noise. With this approach the breast interior is rather small
and depends on the maximum Euclidean distance computed from the breast pixels to the
skin-line. To determine this distance, we first calculate the Euclidean distance from all
breast pixels (the pixels that are enclosed by the pectoral muscle boundary, the skin-line
and the image edge) to the skin-line. Of these distances we take the maximum. In most
cases, the point with the maximum distance to the skin is located on the pectoral muscle or
breast boundary, but it is noted that depending on the shape of the breast this point may also
be located more inward from the boundary. The interior is then defined as the breast pixels
that have at least a distance of 0.4 times the maximum Euclidean distance to the skin-line.
An example is shown in Figure 4.1B.
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A B C
Figure 4.1: A processed mammogram (A) and the segmentation of breast tissue, pectoral muscle
and background (B and C). A graphical representation of the small (B) and large (C) breast interior
are also shown. The breast interior as defined in B) is used to compute F1. The breast interior shown
in C) is used for the computation of F2 and F3.
Reference value F2 - the maximum pixel value in a large breast interior region
In denser breasts, the interior of the breast as defined previously might not contain a pixel
representing only fatty tissue. Therefore, we used a second definition of the breast interior
region in which pixels closer to the skin-line and located within the fully compressed area
are also included.
We defined the larger breast interior as the pixels that have a minimum distance to the skin-
line of half the compressed breast thickness (H). Additionally, we excluded pixels that are
too close to the vertical image edge, as this region is sometimes not representative due to
poor compression, in particular in MLO views. Furthermore, we want to prevent that the
pectoral muscle is part of the breast interior in case it is visible in a craniocaudal (CC) view.
The breast interior pixels have a minimum distance of a quarter of the breast thickness
to the vertical image edge. The breast interior region is given for one mammogram in
Figure 4.1C. To compute the reference value, we again used a large quantile (0.99) of the
pixel value histogram. We call this reference value F2.
Reference value F3 - an estimate from the densest region (minimum pixel value of the mam-
mogram)
When the breast is very dense, the methods above become inaccurate, as it becomes unlikely
that the obtained reference value is representative for the projection of only fatty tissue. In
this section, we propose a method to obtain a suitable reference value using the densest
region in the mammogram. Given the pixel value corresponding to a dense pixel (gdense) at
a certain location r, it is possible to compute the fatty tissue reference value by estimation
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of the corresponding thickness of dense tissue hdense(r). This can be seen if we rewrite
formula 4.1:
F =
g(r)
exp
(−(µd,eff−µf,eff)hd(r))
F3=
gdense
exp
(−(µd,eff−µf,eff)hdense)
(4.3)
The reference value computed in this way is denoted by F3. Note that there is no reference
region in the mammogram with this pixel value, but that it can be derived when we can
estimate hdense at the location of gdense. To find the reference pixel value gdense, we make
use of the large breast interior as used for F2 (see Figure 4.1C) and determine the minimum
using the 0.01 quantile of the pixel value distribution.
To obtain hdense we have to estimate the amount of fibroglandular tissue that corresponds
to the pixel value gdense. Since the reference value gdense corresponds to the densest region
in the mammogram, we assume that it represents the projection of dense tissue and the
layers of subcutaneous fat. Therefore, this pixel value is also representative for the max-
imum dense tissue fraction (MDTF) in the compressed breast projection, i.e. the maximum
thickness of dense tissue in the path of the X-ray beam divided by the thickness of the
compressed breast. Based on this idea hdense is estimated as MDTF ×H with H the com-
pressed breast thickness. To estimate hdense, the MDTF in the direction of the X-ray beam
is needed. As this information is unavailable, we calculate the MDTF in the image plane
and assume that this value is representative for the MDTF in the direction of the X-ray
beam. To make this approach work, two key assumptions need to be fulfilled: 1) in a first
approximation the MDTF is direction independent with respect to a rotation around the
anterior-posterior axis and 2) that the MDTF does not change when the breast is com-
pressed. In section 4.3.5 we investigate to what extent these assumptions are valid by using
MRI data. TheMDTF in the image plane is calculated by constructing paths that represent
plausible X-ray trajectories through the breast when it would be decompressed, rotated by
90 degrees, and compressed again. We used slightly curved instead of linear paths, to take
into account that when imaging a compressed breast the X-ray beam will be approximately
perpendicular to the skin and the subcutaneous fat layer.
The curved paths are defined by taking points on a circle centred at a point (P) outside of
the breast. A schematic overview is shown in Figure 4.2. To define this point P, we cal-
culate the minimum distance between the nipple (N) and the pectoral muscle (M). In CC
views, we used the vertical image edge instead of the pectoral boundary. The point P has
a distance to the nipple of two times the distance NM and lies on the straight line with the
points N and M. The nipple is assumed to be located on the skin-line at the position with
the maximum distance to the pectoral muscle or the vertical image edge for MLO views
and CC views, respectively.
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Figure 4.2: A schematic view of the land marks nipple (N), closest point (M) of the nipple to the
pectoral muscle / image edge, for MLO and CC views, respectively, and the new point P. In the
example of the CC view (right side) are also two curved paths given. All points of a counting path
have the same distance to the point P.
To estimate MDTF in the plane of the mammogram we first classify all pixels as dense
or non-dense with a Random Forest classifier on a rescaled 200 µm image, using features
similar to the ones used in Kallenberg et al. [101]. Then, for each path, we count the num-
ber of dense and non-dense pixels. To minimise variation we group paths to bands with a
width of 0.2 mm with a sliding window approach and calculate the dense tissue fraction
of these bands. The MDTF of a mammogram is the absolute maximum of the dense tis-
sue fractions. To estimate hdense, we use the MDTF averaged over all mammograms of
an examination (left and right breast, and MLO and CC view), to minimise variation. The
MDTF of the MLO and the CC view are assumed to be similar due to the rotation invari-
ance of the MDTF, while theMDTF of the left and right breast are assumed to be similar as
the amount of breast density and the breast density distribution of the left and right breast
are comparable to each other. Only paths with a minimum distance of NP+H/8 are in-
cluded, to exclude paths that are too close to the nipple. Furthermore, we exclude paths
that are too close to the pectoral muscle to prevent that inaccuracies in the pectoral muscle
segmentation influence the result. We also use a distance of H/8 here. Using the thickness
of the compressed breast H we estimate hdense by computing MDTF×H.
4.2.4 Combination of fibroglandular tissue volume estimations
Previous studies showed that the breast density estimates obtained with F1 provide accurate
results for non-dense breasts. However, the reference values F2 and F3 were obtained under
the assumption that the breast is dense. Hence, it is likely that the breast density estimations
obtained with these reference values do not give accurate results in non-dense breasts. In
this study, we developed two hybrid approaches that combine the breast density estimations
to obtain suitable results for the complete range of breast densities.
The first combination scheme takes only into account results from F1 and F2. Based on
the MDTF a threshold t is set. If MDTF is below that threshold, the fibroglandular tissue
volume estimate obtained with F1 is used. Otherwise we use results from reference F2.
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The second combination scheme of the breast density estimates involves three parameters
(t, a and b) and results from the three reference values are combined. The first parameter is
a threshold (t). IfMDTF is below that threshold, the fibroglandular tissue volume estimate
obtained with F1 is used. In case of aMDTF above that threshold, a linear combination of
the other two fibroglandular tissue volume estimations is used, where the weights depend
on the MDTF . The combination scheme can be written as
VDT =
{
VDT1 if MDTF < t
(1−w)×VDT2+w×VDT3 if MDTF ≥ t (4.4)
with w= a×MDTF+b and VDT1, VDT2 and VDT3 the dense tissue volumes obtained
with the reference values F1, F2 and F3, respectively.
In the evaluation, five fold cross validation was used to obtain optimal values for the para-
meters. The data set was divided into five groups, or folds, of equal size. To avoid bias
all exams of a woman were in the same fold. Then, four folds were used to optimise the
parameters, which were then applied on the fifth fold. This process was repeated such that
the obtained parameters were once applied to each fold. The parameters were obtained by
minimising the sum of the squared residuals in the comparison of percent density between
mammography and MRI averaged per breast.
4.2.5 Breast volume
In this work, we used two approaches to estimate the breast volume. The first one is based
on the semi-circle model [102]. In that approach, which was applied in van Engeland, the
interior is assumed to consist of parallel planes, while the peripheral zone is approximated
by semi-circles. The thickness as a function of the compressed breast thickness (H) and the
Euclidean distance between the breast pixel location and the skin-line (d(r)) is given with
the following formula:
h(r) =
 2
[
(H/2)2− ((H/2)−d(r))2
]1/2
if d(r)< H/2
H if d(r)≥ H/2
(4.5)
The second breast volume estimate algorithm used in this study is based on the work of
de Groot et al. [103]. That method uses a model where the peripheral zone of the breast
in the lateral direction, i.e. the region where tissue is not in contact with the compression
paddle, is assumed to be have half the width of the peripheral zone in the posterior-anterior
direction, due to forces related to the attachment of the breast to the chest wall.
To segment the peripheral zone, de Groot performs a sequence of scaling with a factor of
two along the rows, erosion, dilation and rescaling of the segmented mammogram. The
pixels in the lateral direction that are closer to the skin-line than H/4 are considered to
belong to the peripheral zone, while in the posterior-anterior direction pixels closer than
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H/2 are included. The different steps are shown in Figure 4.3.
Since the description proposed by de Groot et al. is for CC mammograms only, we adapted
this approach for MLO views. We introduced a coordinate system in which the y-axis
is defined by the pectoral muscle boundary, and the x-axis is perpendicular to the y-axis
and goes through the nipple position. For each point within the breast segmentation, we
determined the absolute angle (|α|) between the x-axis and the line going through that
point and the origin. Points that were closer to the skin-line than
H
2
(
1− |α|
pi
)
(4.6)
were considered to belong to the region that is not in contact with the compression plate.
Figure 4.4 shows a MLO mammogram with the coordinate system. Like in de Groot, we
used H, obtained from the DICOM header, as thickness for the fully compressed breast
region, and a thickness ofHpi/4 (average thickness of the peripheral zone) for the peripheral
zone. The breast volume is the integral over the breast thickness over the breast area.
4.2.6 Segmentation of MR images
For evaluation of the methods we used breast MRI scans. First, theMRI scans were segmen-
ted into breast tissue and background. Each breast voxel was then labelled as fibroglandular
tissue or fatty tissue. For most MRI’s this was performed automatically with a previously
developed method [104]. Some images were segmented manually. A manual segmentation
was necessary, when the automatic segmentation was not accurate enough judged by a radi-
ologist. Manual segmentations were performed by a trained researcher and were reviewed
by a radiologist with expertise in breast MRI.
Manual segmentation was done as follows: In the axial view, in every 5-10 slices a contour
was drawn around the breast outline using spline interpolation. Using these contours, the
breast outline in the remaining slices was computed using a spline surface function to get
the breast mask. These masks were checked and in case of an inaccurate segmentation,
additional contours were drawn until the masks were accurate enough. Within the breast
mask, contours for the segmentation into fibroglandular and fatty tissue were drawn in the
same slices as the contours to segment the breast from background. These contours were
extended to the whole breast with the method mentioned above. Within this fibroglandular
tissue mask a threshold was applied to distinguish fibroglandular tissue from fatty tissue.
Voxels outside the fibroglandular tissue mask but inside the breast mask were considered to
be fatty. Segmentations were performed on bias field corrected images. The N4 bias field
correction algorithm [105] was used.
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 65
4.2. Methods 57
A B C D
Figure 4.3: Image processing steps to determine the breast region that is in contact with the com-
pression plate of a CC image. First, the segmented breast (A) is scaled to half width (B), then an
erosion and dilation with a circle structure element with a diameter of H/4 is applied, leading to the
band at the skin-line (C). That image is then rescaled to the original width (D).
Figure 4.4: A schematic view of an MLO image and the differentiation into the fully compressed
breast region (white) and the region where the breast is not in contact with the compression plate
(grey). The coordinate system is based on the pectoral muscle segmentation and the estimated
nipple position. For each point within the breast, the angle with the x-axis is determined (α). The
two regions are defined by formula 4.6.
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4.3 Experiments
4.3.1 Materials
We made use of 202 pairs of mammography and MR examinations of 119 women recorded
between December 2000 and December 2011 in the Radboudumc. MRI exams and mam-
mograms were performed within two months of each other. All digital mammograms were
acquired on GE Senographe systems using standard clinical settings. For all examinations,
a complete exam consisting of MLO and CC images of the left and right breast was avail-
able. We used the (raw) unprocessed data.
The MR examinations were performed on either a 1.5 or a 3 Tesla Siemens scanner (Mag-
netom Vision, Magnetom Avanto or Magnetom Trio), with a dedicated breast coil (CP
Breast Array, Siemens, Erlangen, Germany). The segmentation of breast and fibroglandu-
lar tissue was performed on pre-contrast T1-weighted MR volumes without fat saturation.
For 159 MRI examinations the automated segmentation was approved by a radiologist, 43
MRI’s were segmented manually.
4.3.2 Comparison of mammography based fibroglandular tissue estimations to MRI data
The fibroglandular tissue volume estimations obtained with the three different reference val-
ues and the two combined approaches were compared to estimations based on MRI data.
Results were averaged over MLO and CC views to obtain an estimate per breast. For an es-
timation per exam results were averaged over the left and right breast. Pearson’s correlation
coefficients and 95% confidence intervals (CI) were calculated using the statistical software
package R. Because of the log-normal distribution of the data, correlation coefficients were
computed after converting the measurements using the natural logarithm [52,53].
4.3.3 Comparison of breast volumes based on mammography and MRI
Mammographic breast volumes obtained with the two different geometrical approaches,
the semi-circle model and the adaption of de Groot et al., were compared to breast volumes
based on MRI data. Results were averaged over both mammographic views and over the
left and right breast to obtain a single score for each exam. The MRI based breast volumes
of the left and right breast were averaged as well. Pearson’s correlation coefficients and
95% CI were calculated. Based on the performance of the two algorithms, we decided to
proceed with one algorithm for further computations.
4.3.4 Evaluation of volumetric percent density estimations
The percent density estimations obtained with the three different reference values and the
two combined estimates were compared to the estimations based on MRI data. Percent
density is defined as fibroglandular tissue volume divided by breast volume. We made use
of the breast volume estimations that are based on the work of de Groot et al. In the original
work of van Engeland the semi-circle model was used to obtain the breast volume. For
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comparison, percent density is given based on the fibroglandular tissue estimations with F1
and the breast volumes estimations of the semi-circle model as well. The estimations were
again averaged over MLO and CC views to obtain an estimate per breast. To get an es-
timation for each exam, estimations were averaged over the left and right breast. Pearson’s
correlation coefficients and 95% CI were calculated.
4.3.5 Testing rotation invariance and effect of compression
To obtain a fatty tissue reference value with the dense tissue reference region approach we
assume that the maximum dense tissue fraction (MDTF) in the direction of the mammo-
graphic compression (the direction of the X-ray beam) is the same as the MDTF in the
image plane. This assumption is based on the idea that the MDTF does not depend on
the direction of the measurement and is not affected by deformation of the breast due to
compression. To investigate the validity of this idea we used the previously described data
set of 202 MRI exams of 119 women. Additional, we included exams of 20 women who
underwent MR guided biopsies and had breast density categorised as either BI-RADS 3 or
4. For each of these 20 women two MRI exams were available: An MRI recorded with the
breast under compression in the MR guided biopsy procedure and a regular diagnostic MRI.
The compression of the biopsied breast was always in the mediolateral direction. All MR
images were manually segmented into fibroglandular tissue, fatty tissue and background.
To verify the rotation invariance of the MDTF measurements, we took samples in regu-
lar (uncompressed) MRI exams along lines in multiple directions in the coronal planes.
Samples in each direction were taken on a regular grid in a square region of 6× 6cm2,
were the centre of the square region projected to the centre of the breast. By doing so, we
prevented taking samples close to the pectoral boundary or near the breast edge. Samples
had a cross section of 2× 2mm2. In each of these samples the fraction of dense tissue
was computed from the segmented MRI. The MDTF was computed as a function of the
projection angle by taking the maximum dense tissue fraction in the square region while
rotating the breast. We took samples using 36 different angles, ranging between 0 and 175
degrees in steps of five degrees, simulating 36 different projection directions. The mean
MDTF and the coefficient of variation when changing the projection angle were computed
and displayed with a scatter plot. For this experiment we used both the set of 20 MRI’s of
uncompressed dense breasts and the 202 segmented MR images. In Figure 4.5A a coronal
slice of a MRI volume is given. The sample direction is craniocaudal.
In a second experiment we looked at the effect of compression using the exams of the
patients who underwent MR-guided breast biopsies. We determined the maximum dense
tissue fraction in the MRI’s of the compressed breasts in two directions, one in the com-
pression direction and one perpendicular to it, both along lines in parallel with the chest
wall. These correspond to the directions in which we compute the maximum dense tis-
sue fractions in the mammograms, with the difference that the MRI’s are compressed in
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A B
Figure 4.5: Two MRI exams of the same patient: A) A coronal slice of an regular MRI volume,
with an arrow indicating the craniocaudal direction in which the dense tissue fraction is determined,
and B) a coronal slice of an MRI volume recorded in a MR guided biopsy procedure, in which the
dense tissue fraction was determined in two directions: mediolateral and craniocaudal as indicated
by vertical and horizontal arrows, respectively.
mediolateral directions while mammograms are compressed in the mediolateral oblique or
craniocaudal direction. A visual example is shown in Figure 4.5B.
4.4 Results
4.4.1 Fibroglandular tissue volume
Figure 4.7 shows the results of the five methods for dense tissue volume estimation using
MRI as a reference. The Pearson’s correlation coefficients for the comparisons with MRI
were 0.79, 0.80, 0.73, 0.83 and 0.86 when using F1, F2, F3, the combination of F1 and
F2, and the combined estimates of F1−F3, respectively. In Table 4.1 the correlation coef-
ficients are given for the estimations averaged per breast and per exam.
The parameters t, a and b that are needed to combine the results were obtained through
cross validation. The optimal values for the parameters were determined in each fold and
varied only a little. For both approaches, when combining F1 and F2, and when combining
all three estimates, the optimal threshold was set to 0.35 (in four of the five folds). There-
fore, the fibroglandular tissue volume as estimated with F1 is used if the MDTF < 0.35.
The parameters a and b are needed when combining all three fibroglandular tissue volume
estimates. In the majority of folds, the optimal values for a and bwere 1.4 and -0.8, respect-
ively. TheMDTF is a first indication for the density. So in non-dense breasts the estimates
as obtained with F1 are used while for dense breasts a combination of F2 and F3 works
best.
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per breast per exam
F1 0.77 (0.73-0.81) 0.79 (0.73-0.84)
F2 0.78 (0.74-0.81) 0.80 (0.74-0.84)
F3 0.71 (0.66-0.75) 0.73 (0.66-0.79)
combination F1 and F2 0.81 (0.78-0.84) 0.83 (0.78-0.87)
combination F1, F2 and F3 0.83 (0.80-0.86) 0.86 (0.81-0.89)
Table 4.1: Pearson’s correlation coefficients with 95% CI for the five fibroglandular tissue volume
estimations.
4.4.2 Breast volume
Figure 4.6 shows results of the two breast volume estimation methods in comparison to
MRI. Breast volume based on mammography has a linear relationship with the breast
volume calculated from the MR images with both approaches. A Pearson’s correlation
coefficient of 0.96 (0.95-0.97 95%CI) was obtained for the semi-circle model and for the
model in which the breast region that is in contact with the compression plates has a dir-
ection dependency. We decided to use the second approach, which is based on the idea of
de Groot et al., for further calculations. This method appears to have less bias as the data
points are closer to the identity line.
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Figure 4.6: Comparisons of breast volume obtained with MRI and mammography, averaged per
examination. In figure A) are the estimations with the semi-circle model, while in figure B) the
estimates based on the idea of de Groot et al. are displayed, where the definition of the fully com-
pressed breast region has a direction dependency.
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 70
62 Volumetric breast density estimation in digital mammograms
0 100 200 300 400 500
0
10
0
20
0
30
0
40
0
50
0
Dense Volume MRI ( cm3 )
D
en
se
 V
o
lu
m
e 
D
M
 ( c
m3
 
)
R = 0.79
A) reference value F1
0 100 200 300 400 500
0
10
0
20
0
30
0
40
0
50
0
Dense Volume MRI ( cm3 )
D
en
se
 V
o
lu
m
e 
D
M
 ( c
m3
 
)
R = 0.80
0 100 200 300 400 500
0
10
0
20
0
30
0
40
0
50
0
Dense Volume MRI ( cm3 )
D
en
se
 V
o
lu
m
e 
D
M
 ( c
m3
 
)
R = 0.73
B) reference value F2 C) reference value F3
0 100 200 300 400 500
0
10
0
20
0
30
0
40
0
50
0
Dense Volume MRI ( cm3 )
D
en
se
 V
o
lu
m
e 
D
M
 ( c
m3
 
)
R = 0.83
0 100 200 300 400 500
0
10
0
20
0
30
0
40
0
50
0
Dense Volume MRI ( cm3 )
D
en
se
 V
o
lu
m
e 
D
M
 ( c
m3
 
)
R = 0.86
D) combination of reference value F1 & F2 E) combination of the three reference values
Figure 4.7: Comparison of fibroglandular tissue volume estimates per exam. In the subfigures A-C,
the closed circles belong to cases with aMDTF below 0.35, open circles have aMDTF above 0.35.
In the figures D-E, closed circles are used for exams that use the estimation of F1, while open circles
are used when F2 (in D) or the combination of F2 and F3 (in E) is used.
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Figure 4.8: Comparison of percent density estimations per exam. In A) the breast volume is es-
timated with the semi-circle model. For the results in B-F the breast volume as obtained from the
second algorithm was used.
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 72
64 Volumetric breast density estimation in digital mammograms
4.4.3 Volumetric breast density estimation
Figure 4.8 shows the comparison between volumetric percent density estimates from mam-
mography and MRI. The Pearson’s correlation coefficients between the volumetric percent
density estimations per study were 0.86, 0.89, 0.74, 0.89 and 0.90 when using F1, F2, F3,
the combination of F1 and F2 and the combination of F1−F3, respectively. When us-
ing the fibroglandular tissue estimations with F1 and the semi-circle model for the breast
volume a correlation of 0.88 was found. Pearson’s correlation coefficients with 95% CI are
shown in Table 4.2 for comparisons per breast and per exam.
per breast per exam
F1 with semi-circle model 0.87 (0.84-0.89) 0.88 (0.84-0.91)
F1 0.84 (0.81-0.87) 0.86 (0.82-0.89)
F2 0.87 (0.85-0.89) 0.89 (0.86-0.91)
F3 0.73 (0.68-0.77) 0.74 (0.67-0.80)
combination F1 and F2 0.87 (0.84-0.89) 0.89 (0.85-0.91)
combination F1, F2 and F3 0.89 (0.87-0.91) 0.90 (0.88-0.93)
Table 4.2: Pearson’s correlation coefficients with 95% CI for the six volumetric density estimations.
When not indicated the breast volume as obtained with de Groot et al. was used.
4.4.4 Rotation invariance and the effect of breast deformation
We determinedMDTF values for different projection angles in the MR images of 20 dense
breasts and the 202 segmented MR volumes. With a rotation interval of 5 degrees, this
yielded to MDTFs of 36 different angles. The mean MDTF ranged between 0.11 and
0.95 and the coefficient of variation of the measurements ranged between 0.01 and 0.54. In
Figure 4.9A a scatter plot of the meanMDTF and the coefficient of variation is shown. We
see that the coefficient of variation decreases with an increase of the meanMDTF . The low
coefficient of variation of dense breasts (high mean MDTF), indicates that the MDTF is
almost direction invariant in extremely dense breasts. On the other hand, the coefficient of
variation is larger of small meanMDTF ′s. As theMDTF is a first indication for the breast
density, we can see that the idea of direction invariance is violated in non-dense breasts.
Hence, it is no surprise that the MDTF used to estimate F3 becomes unreliable, resulting
in unrealistic low dense volume measurements (see also Figure 4.7C).
The comparison of the maximum dense tissue fractions measured in coronal planes of the
compressed breast MRI’s is shown in Figure 4.9B. Results obtained in the mediolateral
direction, the direction of the compression, are on the vertical axis, while results of the
craniocaudal direction are plotted horizontally. It can be observed that the maximum dense
tissue fraction (MDTF) in the two directions are quite similar, which supports the validity
of our approach.
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 73
4.5. Discussion 65
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
mean of the MDTFs
co
ef
fic
ie
nt
 o
f v
ar
ia
tio
n 
of
 th
e 
M
D
TF
s
20 BI−RADS 3+4 breasts
202 MR volumes
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
MDTF craniocaudal
M
D
TF
 m
ed
io
la
te
ra
l
A B
Figure 4.9: A) Mean and coefficient of variation of the 36MDTF measurements of the MR images
of the 20 uncompressed breasts (closed circle) scored as BI-RADS density 3 or 4, and the 202
segmented MR images (open circle). B) Maximum dense tissue fraction measured in MRI’s with
compression of the breast in mediolateral direction. The dense tissue fractions in the direction of the
compression are compared to the perpendicular direction.
4.5 Discussion
Accurate and reliable breast density measurements are needed when using density for strat-
ification or breast cancer risk analysis. In this study, we experimented with the use of
different internal reference values for calibration of a widely used volumetric breast density
quantification method. We used reference values of pure fatty pixels using two different
breast interior definitions and also proposed a novel approach, which employs the densest
region in a mammogram as a reference. Hybrid approaches to obtain robust estimates in
fatty and dense breasts, which combines breast density estimates, are also proposed.
We estimated the reference value of purely fatty tissue based on the pixel value distribution
in the breast interior. The two reference values F1 and F2 use different definitions of the
breast interior. The third reference value F3 was determined based on a pixel value repres-
entative for the densest region in the mammogram. When comparing volumetric percent
density based on mammography to MRI data for each exam, Pearson’s correlation coeffi-
cients of 0.86, 0.89 and 0.74 were found when using F1, F2 and F3, respectively, when
using de Groot to obtain the breast volume estimate.
Results show that the individual performance of F1 and F2 is much better than the one of
F3. Therefore, it might be questionable whether F3 adds a lot to the performance of a hy-
brid approach. However, in our experiments best results were obtained when combining all
three estimations (Pearson’s correlation 0.90). This can be explained by the fact that differ-
ent breast density patterns require different approaches. Compared to the original method,
a clear improvement is visible in the scatter plots when comparing the results to that of
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the combined approach (Figure 4.8), in particular for dense breasts. The combination of
results of F1 and F2 yielded a correlation coefficient of 0.89. Though the difference in
correlation coefficient between the two hybrid methods is small, substantial differences are
visible between the two scatter plots for dense breasts. This confirms that a new approach is
necessary to deal with extremely dense breasts. The difference in correlation found in our
study is not large, we expect larger differences when more cases with dense breasts would
be included in the study set. An analysis with only dense breasts might be carried out in the
future.
The novel method based on using the densest region in a mammogram as a reference re-
lies heavily on the assumption that the maximum dense tissue fraction (MDTF) does not
strongly depend on the projection angle and the compression. We tested the assumption that
theMDTF is rotation invariant in planes in parallel to the chest wall using MRI exams with
segmentations of fibroglandular tissue. For 424 breasts the mean MDTF computed in 36
directions and the coefficient of variation were determined. As expected, the coefficient of
variation decreases with an increase ofMDTF . For extremely dense breasts, the coefficient
of variation becomes as low as 0.05. This indicates that the method we propose is a feasible
alternative to methods relying on a fatty tissue reference region when breasts are dense. It
should also be noted that random errors due to variation of the direction in which the dense
tissue fraction is measured are reduced because in mammography we combine four meas-
urements, the MLO and CC projections of both breasts, into a single density measurement.
For non-dense breasts the method cannot be used because the assumption of rotation invari-
ance is violated.
A second assumption was made that theMDTF in the direction of the compression is com-
parable to the MDTF in a direction perpendicular to the compression force. Results in
Figure 4.9B suggest that this is true in good approximation. For a moderately compressed
breast, as obtained in MRI guided biopsy procedures, the MDTF in both directions are
comparable to each other.
Breast MRI scans were used for validation in which fibroglandular tissue, fatty tissue, and
background were segmented. While some of these segmentations were obtained manually,
most were automatically generated. That we used a mix of two segmentation methods may
be regarded as a drawback since it could introduce an additional source of error. However,
we observed that the range of volumetric breast density estimates of the manual segmented
MRI’s is comparable to the range of estimations obtained with the automatic segmented
MR images (1.7-51.2% compared to 2.4-56.6%). Therefore, we believe that the manually
segmented cases were not systematically denser of less dense than the automatically seg-
mented cases.
In this study, we also investigated two different breast volume computation methods. Ac-
curate estimation of breast volume is important because this is needed to obtain volumetric
percent density. We found that a recently proposed method which extends the semi-circle
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model of the breast edge shape leads to visually improved results when MRI is used as a
reference. In this paper we adapted the method in such a way that it can be applied to both,
MLO and CC, views. Both approaches resulted in a high correlation coefficient when com-
pared to the breast volumes estimations computed from MRI data. However, the methods
have a tendency to underestimate breast volume, but the bias is less prominent in the new
method. This can be seen as well in Figure 4.8A where percent breast density is overestim-
ated as the breast volume of the semi-circle model is underestimated. Some underestimation
might be expected though, since the field of view of both imaging techniques is different.
The imaged part of the breast in a mammogram relies strongly on the positioning of the
patient. With MRI, the complete breasts and parts of the thorax are always imaged.
The algorithm of de Groot to estimate the breast volume defines a contact surface of the
breast and the compression paddle that is slightly different from the one we used for de-
fining the breast interior region for reference value F2. Though we could have used this,
we decided not to use this alternative interior region definition. The reason is that we noted
that due to inclusion of more pixels at the peripheral region border there was a high risk of
including poorly compressed tissue regions close to the chest wall, especially in the MLO
views. Inclusion of such regions might easily lead to large errors in the dense tissue estim-
ation.
A limitation is that the study makes use of mammograms obtained at a single site with a
single vendor. The studies of Wang [52] and Gubern-Me´rida [53] have, however, shown
that breast density can be reliable estimated with the reference method across vendors and
that there is a problem with extremely dense breasts independent of the manufacturer of the
mammographic system. Gubern-Me´rida made use of images obtained with GE equipment,
while Wang et al. used images acquired on Hologic systems. Hence, we do not expect
problems with images from other vendors than GE.
In this study we proposed a novel approach to improve breast density estimation in dense
breasts. By including the densest region in a mammogram as a reference and by adapting
the region in which a fatty tissue reference region is selected we achieved better results com-
pared to the existing approach. Results demonstrate that it remains crucial to find a good
reference value for fatty tissue in order to get a reliable breast density estimate. Different
fibroglandular tissue patterns within the breast require different techniques to estimate the
fibroglandular tissue volume and percent volumetric density.
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Abstract
Purpose: Fibroglandular tissue may mask breast cancers, thereby reducing the sensitivity
of mammography. Here, we investigate methods for identification of women at high risk of
a masked tumour, who could benefit from additional imaging.
Methods: The last negative screening mammograms of 111 women with interval cancer
(IC) within 12 months after the examination and 1110 selected normal screening exams
from women without cancer were used. From the mammograms, volumetric breast dens-
ity maps were computed, which provide the dense tissue thickness for each pixel location.
With these maps, three measurements were derived: 1) percent dense volume (PDV), 2) per-
cent area where dense tissue thickness exceeds 1cm (PDA), 3) dense tissue masking model
(DTMM). Breast density was scored by a breast radiologist using BI-RADS. Women with
heterogeneously and extremely dense breasts were considered at high masking risk. For
each masking measure, mammograms were divided into a high- and low-risk category,
such that the same proportion of the controls is at high masking risk as with BI-RADS.
Results: Of the women with IC, 66.1%, 71.9%, 69.2% and 63.0% were categorised to be at
high masking risk with PDV, PDA, DTMM, and BI-RADS, respectively, against 38.5% of
the controls. The proportion of IC at high masking risk is statistically significantly different
between BI-RADS and PDA (p-value 0.022). Differences between BI-RADS and PDV, or
BI-RADS and DTMM, are not statistically significant.
Conclusion: Measures based on density maps, and in particular PDA, are promising tools
to identify women at high risk for a masked cancer.
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5.1 Introduction
Thanks to screening programs, breast cancers are often detected at an early stage. Never-
theless, not all breast cancers in breast cancer screening participants are actually detected
by screening. Approximately 16-33% of the breast cancer cases are the so-called interval
cancers, which means that they are diagnosed in between two screening rounds [14, 15],
even though the introduction of digital mammography may have led to an increase in sens-
itivity [69, 106]. In general, interval cancers are detected at a later stage with a worse
prognosis [16–18]. Fibroglandular tissue may mask cancers, and therefore sensitivity of
mammography decreases with an increase in breast density. It has been shown that there
is a relationship between breast density and screening program sensitivity [26, 29–32, 92].
In addition, compared to women in the lowest density category, women with dense breasts
also have a higher breast cancer risk [10, 22, 24], which amplifies the negative effect of
masking.
To detect more cancers at an early stage, personalised screening programs have been pro-
posed [33, 34]. Adjusted to the personal needs of individual women, screening could be
offered with different time intervals or with other modalities than mammography, such as
ultrasound or MRI. Tomosynthesis might be an option as well, although the effect is limited
for extremely dense breasts [107]. In this discussion, the reduced sensitivity of mammo-
graphy due to the masking effect of density plays an important role. In recent years, many
states in the United States passed breast density notifications laws. Radiologists are obliged
to inform women about their breast density and the affiliated risks. In some states, addi-
tional imaging is reimbursed for women with dense breasts.
For the measurement of breast density, several methods are available. In clinical practice,
the 4-point ACR BI-RADS scale is commonly used [37, 38]. To make this estimate less
subjective, algorithms have been developed to estimate the breast density by computing
the percentage dense area projected on the mammogram or by computing the percentage
of fibroglandular tissue volume within the breast. An overview of different algorithms is
presented by He et al. [54].
Although breast density relates to masking, the relation between the risk of masking and
density is likely to be more complex than a simple dependence on the amount of fibroglandu-
lar tissue. Also, the distribution of dense tissue may play a role. This is reflected in the
new BI-RADS definition that no longer considers the total amount of fibroglandular tis-
sue within the breast, but rather the densest area [38]. How the risk of masking should be
quantified is an open question. The aim of this study is to compare three different quantit-
ative masking measurements and the visual BI-RADS density assessment of a radiologist,
in their ability to predict the risk of an interval cancer.
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5.2 Materials and Methods
5.2.1 Data
Digital mammograms from the Dutch breast cancer screening program were analysed. The
mammograms were acquired on Lorad Selenia systems (Hologic, Bedford, USA). Women
aged 50-75 years are invited biennially to participate in the screening program. Details
about the screening program and the dataset can be found elsewhere [67, 108, 109]. Writ-
ten informed consent was not required for this study. Women automatically consent to the
use of their anonymised data for scientific purposes by participating in screening. Data of
participants who objected to the use of their data were removed.
The research archive used contains unprocessed mammograms of one screening unit. In the
period 2003-2012, more than 130,000 exams of more than 55,000 women were acquired.
Mediolateral oblique (MLO) images were always taken, while craniocaudal (CC) images
were taken in the first screening round and in 60% of subsequent rounds. Through linkage
with the Netherlands Cancer Registry and the screening organisation, 1210 breast cancers
were identified, of which 836 were screen-detected cancers. The remaining 374 breast can-
cers were diagnosed outside the screening program. Of these interval cancers, 275 were
diagnosed within 24 months (screening interval), of which 113 cancers within 12 months
after the examination. The last available screening examination before cancer diagnosis is
used in this study. Women with breast implants were excluded from the study as the density
map cannot be correctly computed for mammograms with implants.
In this study, a selection of the interval cancers, the cancers that were diagnosed within 12
months after the examination, is used (N=111, two women were excluded because of breast
implants). The reason is that we want to focus on false negative exams due to masking.
Interval cancers may also be due to other factors. In particular, fast growing cancers may
not be detectable at the time of screening because they still are too small or not yet invasive.
We assume that by excluding interval cancers detected more than 12 months after screen-
ing, a larger proportion of the interval cancers are due to masking. This idea is supported
by Weber et al. [110] who found that a larger proportion of the interval cancers found in the
second year after the screening examination show no signs of abnormality in the screening
mammogram compared to the interval cancers found in the first year.
For each patient with an interval cancer, 10 participants were chosen as controls. The con-
trol participants needed to have had a mammographic examination in the same month in
which the last screening examination of the interval cancer patient was performed. To be
eligible as control, the women should not have been recalled on the basis of this mammo-
graphic examination and they should not have been diagnosed with breast cancer within
2 years after this examination. Women with breast implants were not eligible as control.
Controls without a density map, due to failure of the computation, were replaced.
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5.2.2 Methods
Quantitative masking risk measures based on volumetric breast density measurements were
computed. For this purpose, a research version of the commercial software Volpara (v1.5.0,
Volpara Health Technologies, Wellington, New Zealand) was used, which provides a quant-
itative breast density map in addition to the percentage of dense tissue volume. In these
density maps, the pixel intensity is mapped to the fibroglandular tissue thickness at each
pixel location.
Three different automated measurements were investigated to estimate masking risk: 1)
percent dense volume (PDV), defined as the fibroglandular tissue volume divided by the
breast volume; 2) percentage dense area (PDA), computed as the percentage area on the
density map where the dense tissue thickness exceeded 1 cm; and 3) a dense tissue mask-
ing model (DTMM) in which the size distribution and cancer location probability are taken
into account. The idea behind the second method is that a certain amount of fibroglandular
tissue is necessary to hide a cancer. With the threshold of 1cm, the size of a region where
cancers may be masked is estimated and we assume that the relative area of this region is
related to masking risk. A strength of this method is the simplicity. In the third method,
this idea is refined with the tissue masking model which captures two aspects. First, instead
of using a fixed thickness threshold, it is modelled that larger cancers require more dense
tissue to be masked than smaller cancers. For this, the normalised distribution of breast
cancer size is taken into account. Second, the probability distribution of cancer location
is used to consider that dense tissue presence in regions where cancers more often occur
should give a stronger increase in masking risk than dense tissue presence elsewhere. A
detailed description is in Box 5.1.
The methods were applied to all available images in an exam, i.e., MLO and CC views
of both breasts. If CC views were missing, their results for the different methods were
imputed. This was done for each method separately using linear regression analysis in con-
trols with both MLO and CC views available. To come to a single score per exam, results
were averaged over the four views.
Next to the automated measurements, for the purpose of this study, the breast density cat-
egory of every exam was assessed by a radiologist (10 years of experience in breast ima-
ging) according to the fifth edition of the BI-RADS atlas [38]. Mammograms were evalu-
ated without knowledge of the cancer status.
To implement supplemental screening strategies in clinical or screening practice, it is neces-
sary to divide the women into two groups: women at low masking risk and women at high
masking risk. In practice, a threshold needs to be determined and all women with a meas-
ure above the threshold would receive additional imaging. The best threshold is unknown
for the automated measures and depends on the screening population and the proportion of
women that one is willing to offer supplemental screening or the number of interval cancers
that should be detected with additional imaging.
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Box 5.1 The dense tissue masking model
The dense tissue masking model (DTMM) captures two aspects: 1) the larger the le-
sion, the lower the masking risk; and 2) the larger the dense tissue thickness at a loca-
tion, the higher the masking risk. Therefore, the masking risk for a lesion with diameter
dt at a location with density d is defined as
masking(dt ,d) =
d−dt
d
if d  dt (5.1)
From this, the masking risk for each pixel location (x,y) is estimated by summing over
all possible tumour diameters considering the normalised cancer size distribution s(dt).
The size distribution was obtained for invasive masses. In the mammograms, a contour
was drawn around the mass and the effective diameter was determined (diameter = 2
(area/pi)1/2). The distribution was normalised to a value of one. With the use of the
size distribution we take into account that lesions with the size of few millimetres are in
general not detectable and that extremely large cancers are not common in screening.
The masking risk at a location (x,y) with density d(x,y) is then
masking(x,y) =
dt=d(x,y)
∑
dt=0
s(dt)×masking(dt ,d(x,y))
=
dt=d(x,y)
∑
dt=0
s(dt)× d(x,y)−dtd(x,y)
(5.2)
Furthermore, the cancer location probability distribution (CLPD) is taken into account.
With the use of the CLPD, it is acknowledged that lesions are more common in the
centre of the breast and less common close to the periphery. The CLPD was as well
obtained with the invasive mass-like lesions as described in [111]. The probability of
masking is then:
masking(x,y) =CLPD(x,y)×
dt=d(x,y)
∑
dt=0
s(dt)× d(x,y)−dtd(x,y) (5.3)
With the formula above, the masking risk is determined for each pixel location (x,y).
To come to a single score for each image, the masking risk is averaged over all pixels
within the breast. Different CLPDs and size distributions were used for the MLO and
CC images.
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To measure to what extent the methods can identify women at high masking risk, the mam-
mograms were divided in a high and low masking risk group by thresholding the risk meas-
ure. Then, the sensitivity of the masking measures was computed as the number of interval
cancers in the high-risk group divided by the total number of interval cancers. The false
positive rate is calculated as the percentage of normal controls selected as at high masking
risk at the same threshold. In the context of risk stratification for supplemental screening,
the proportion of controls selected as at high masking risk can be seen as supplemental
screening rate and the proportion of interval cancers gives an estimate about the cancers
that might be detectable with additional imaging at that supplemental screening rate.
The automated masking measures were compared to the radiologist scores when distin-
guishing BI-RADS density a and b versus BI-RADS density c and d. Bootstrapping was
used to obtain 95% confidence intervals (CIs) and derive p-values.
Since breast density is a risk factor for breast cancer [10,22,24], it may be expected that the
average breast density of women with cancer is higher than that in controls. Consequently,
any predictive value of PDV for the presence of interval cancers might be caused by PDV
being a risk factor, rather than being a ’masking factor’. To investigate the potential impact
of this effect on our results, an additional experiment was conducted in which it was tested
to what extent PDV can distinguish women with any breast cancer from controls. Again,
cases with the highest PDV were selected by thresholding, and the proportion of cancers as
a function of the proportion of controls selected was computed. For this experiment, mam-
mograms of the screen-detected breast cancers and the interval cancers detected within 24
months were used. Only the interval cancers detected later than 24 months after the last
examination were not used, as we assume that these cancers might well have been detected
when women would have attended another screening round.
5.3 Results
The mean age of interval cancers and controls is 57.7 and 59.2 years, respectively. In 14.4%
of the interval cancers, the cancer was diagnosed after first participation in the screening
program, while 15.2% of the controls belong to women who attended the screening pro-
gram for the first time. Only 3 interval cancers (2.7%) were diagnosed in women older than
70 years, while 110 women (11%) of the control group were older than 70 years.
In Figure 5.1, the percentage of interval cancers selected as at high masking risk is plotted
against the percentage of controls selected when thresholding the different masking meas-
ures. As mentioned earlier, the proportion of controls selected as at high masking risk can
be interpreted as the supplemental screening rate when a masking measure would be used in
practice to identify women eligible for supplemental screening. The percentage of interval
cancer selected as at high masking risk is a measure for the potential benefit of supple-
mental screening, since it is the proportion of women with interval cancers that would have
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Figure 5.1: By thresholding the masking measures, cancers and controls were separated into high
and low risk groups. The percentages of cancers and controls in the high-risk group are plotted
against each other as function of the threshold.
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Figure 5.2: By thresholding the PDV measure the cancers and controls were separated into a high-
risk and a low-risk group. The figure shows the proportion of cancers and controls in the high-risk
group as function of the PDV threshold.
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been included in the selection if supplemental screening had been offered. The percentage
of interval cancers selected for several supplemental screening rates is given in Table 5.1A,
while the supplemental screening rate required to include a certain percentage of women
with interval cancer is presented in Table 5.1B.
The density scores determined visually by the radiologist were used to differentiate non-
dense breasts from dense breasts, using the BI-RADS b-c transition as threshold. With
BI-RADS, 38.5% (CI: 35.7-41.3) of the controls were considered dense and thus at high
masking risk. Of the interval cancers, 63.0% (CI: 53.5-72.0) were classified as dense, using
BI-RADS. If the thresholds of the three masking measurement methods were set such that
there too the proportion of controls classified as at high masking risk was 38.5%, then 66.1%
(CI: 55.8-76.2), 71.9% (CI: 63.1-80.2) and 69.2 (60.0-77.9) of the women with an interval
cancer were considered at high masking risk with PDV, PDA and DTMM, respectively.
Significantly more women with interval cancers would be included in the selection process
with PDA compared to BI-RADS (p-value 0.022). Differences in proportions between BI-
RADS and PDV, and BI-RADS and DTMM were not statistically significant with p-values
of 0.187 and 0.067, respectively.
The ability of PDV to distinguish breast cancers from controls is displayed in Figure 5.2.
The cancers detected at a screening examination (N=836) and the interval cancers that were
diagnosed within the screening interval of 24 months after a negative screening examina-
tion (N=275) were eligible for the analysis (N=1,111). The PDV estimate was available for
1,103 cancers. The curve for predicting interval cancers shows a much higher area under
the curve than the curve predicting all breast cancers. These results show that PDV is not
’just’ a predictor for breast cancer risk, but in particular a good predictor for the risk of
developing an interval cancer (as a proxy for risk of masking).
5.4 Discussion
In this study, we investigated the ability of several measurements of masking risk to distin-
guish false negative screening mammograms from true negative screening mammograms.
The aim of our work is to find a method that is suited to identify women who are at high risk
to be diagnosed with an interval cancer after a negative screening exam. In a personalised
screening work flow, such a method could be applied to all negative screening mammo-
grams to select the subgroup of women who would benefit most from additional imaging
with MRI or ultrasound.
There are various reasons why interval cancers are not detected by screening, and masking
is only one of them. Some cancers may be not detected by screening because they grow
fast and the screening interval is too long. As we focus in this study on masking, we in-
cluded in our experiment only those interval cancers that were diagnosed within 12 months
after the negative mammogram, to exclude true interval cancers, the cancers that show no
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 87
5.4. Discussion 79
A B
percentage percentage
of PDV PDA DTMM of interval PDV PDA DTMM
controls cancers
5 14.4 18.9 14.4 5 1.4 1.4 2.0
10 27.9 29.7 27.0 10 4.3 2.4 4.1
15 40.5 34.2 40.5 15 5.0 3.3 5.5
20 45.9 45.9 47.7 20 5.9 5.1 7.1
30 54.1 64.0 60.4 30 10.3 11.0 11.7
38.5 66.1 71.9 69.2 40 13.7 17.4 15.0
40 70.3 73.0 69.4 50 22.9 22.8 21.9
50 77.5 79.3 79.3 60 33.2 27.1 29.1
70 39.6 36.2 40.1
80 51.4 50.5 51.5
90 61.7 67.6 67.8
Table 5.1: On the masking measures, a threshold can be applied to separate cases and controls into
a high-risk and a low- risk group. By adjusting the threshold on a masking measure the percentage
of controls (also interpretable as supplemental screening rate) is adjusted. The percentage of interval
cancers that would be included in the selection at several supplemental screening rates is given in
subtable A. Using BI-RADS breast density c and d as high-risk categories, 38.5% of the controls
are considered at increased masking risk and 63.0% of the women with interval cancer would be
included in the selection. The threshold on the masking measure can be adjusted such that a specific
percentage of the women with interval cancer is included in the high-risk group. The corresponding
percentage of controls (supplemental screening rate) is given here for several percentages of interval
cancers and the different masking measures in B. In total 111 cancers and 1110 controls were used.
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signs of abnormality on the mammogram. True interval cancers are more common in the
second year after the examination than in the first year [110]. Given that the exact cancer
location was unknown and that the diagnostic mammograms were not available, it was not
possible to review the interval cancers and to confirm that masking is the cause for a cancer
diagnosis outside the screening program. It is noted that by excluding the interval cancers
after 12 months, our study results are also more representative for screening programs with
a 1-year interval.
In current clinical practice, the BI-RADS density assessment categories are used to decide
whom to offer supplemental screening. Using a separation into a low-risk group (BI-RADS
density a and b) and high-risk group (BI-RADS density c and d) with a 38.5% supplemental
screening rate, it was found that between 63.0% and 71.9% of the women diagnosed with
an interval cancer in the study data within 12 months of a negative screening would be in-
cluded in the high-risk group for additional imaging. Automated measures have a higher
sensitivity than the radiologist, and this difference was statistically significant for the new
proposed measurement PDA at the chosen supplemental screening rate.
We compared the ability of PDV to distinguish cancers (screen-detected and interval) from
controls to make sure that we capture more than the breast cancer risk in relation to breast
density. Thereby, we confirmed that cancers are more common in dense breasts than in
non-dense breast. Nevertheless, we can conclude that the differences in PDV distributions
of interval cancers and controls are not only caused by the increased breast cancer risk that
is associated with an increased breast density, and that PDV is capturing masking.
Cancers and controls were only matched for the month of acquisition and not for age and
participation in the breast cancer screening program. The mean age of the controls was
higher than the mean of the cases. Given that breast density decreases with age [25], one
could argue that the difference in density distribution between cases and controls is caused
by differences in age. However, the control group contained more women who participated
in the screening program for the first time than the cases, leading to an effect in the opposite
direction. While only three interval cancers (2.7%) were found in women between 71 and
75 years of age, 11% of the controls belong to this age group causing the higher mean age
in controls. If we had matched for age at the time of acquisition, women above 70 years
would have been under-represented in the controls, and the controls would have been not
representative for the screening population.
Mainprize et al. [112] have been working on the quantification of masking as well. In their
model, a detectability map is created for each pixel location by simulating lesions and by
using local estimates of the noise power spectrum and volumetric breast density. They val-
idated the masking measurement with an observer study on regions of interest of 150 cancer
free CC mammograms. High correlations were found between the mean value of the de-
tectability maps and the computerised and human observer study. However, Mainprize only
used cancer free mammograms in his study and simulations in regions of interests. Hence,
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it remains an open question to which extent the mean value of the detectability map differs
between false and true negative screening mammograms and whether it can be used as a
predictive masking score.
A limitation of our study is the fact that CC images were not available for all exams. Until
recently, MLO was the standard view in the screening program where we acquired our data,
while CC images were obtained by indication. Therefore, to avoid bias when averaging over
views, we imputed data for missing CC views based on the available MLO view and statist-
ical analysis of differences between MLO and CC views. Furthermore, cases and controls
were matched to the month of acquisition to guarantee the same guidelines and circum-
stance in image acquisition with regard to taking the CC views. Another limitation is that
BI-RADS density assessments of only one radiologist were available. Many studies found
inter- and intra-reader variability in breast density assessment using BI-RADS [41–43,49].
Therefore, to make a definitive comparison between the automated methods and radiolo-
gists assessments, an extensive reader study should be conducted with multiple readers.
In conclusion, results suggest that the new proposed masking risk measurements may have
a better performance than visual BI-RADS assessment in distinguishing false negative
screening mammograms from true negative screening mammograms. Therefore, these
measurements may be considered as predictive masking measure when implementing sup-
plemental screening for women at a high risk for interval cancers.
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Abstract
Purpose: To determine the effect of breast compression pressure in mammography on
breast cancer screening outcomes.
Materials and Methods: We used digital image analysis methods to determine breast
volume, percent dense volume and pressure from 132,776 examinations of 57,187 wo-
men participating in the Dutch population-based biennial breast cancer screening program.
Pressure was estimated by dividing the compression force by the area of the contact surface
between breast and compression paddle. The data was subdivided into quintiles of pres-
sure and the number of screen-detected cancers, interval cancers, false positives, and true
negatives were determined for each group. Generalized estimating equations were used
to account for correlation between examinations of the same woman and for the effect of
breast density and volume when estimating sensitivity, specificity, recall rate, false positive
rate and positive predictive value. Sensitivity was computed using interval cancers occur-
ring between two screening rounds and within 12 months after screening. Pair-wise testing
for significant differences was performed for sensitivity and specificity measurements.
Results: Sensitivity in quintiles with increasing pressure was 82.0%, 77.1%, 79.8%, 71.1%,
70.8%. The 12 month sensitivity was significantly lower in the highest pressure quintile
compared to the third (84.3% vs 93.9%, p = 0.034). Specificity was lower in the lowest
pressure quintile (p<0.005) compared to the second, third and fourth group, with a spe-
cificity of 98.0%, 98.5%, 98.5%, 98.5%,and 98.4% respectively.
Conclusion: Results suggest that if too much pressure is applied during mammography
this may reduce sensitivity. In contrast, if pressure is low this may decrease specificity.
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6.1 Introduction
In mammography, breast compression is applied to reduce the thickness of the breast. This
results in improved image quality, because tissue superposition and X-ray scatter are re-
duced, while it limits the required dose [113–116]. In addition, with a compression paddle
the breast can be kept in a fixed position, which reduces the risk of motion artefacts and
image blurring.
Mammography devices measure and display compression force during the imaging proced-
ure. However, there are no quantitative guidelines regarding the compression force a radio-
grapher should apply for acquisition of an adequate mammogram. In practice, compres-
sion force in mammography varies widely among radiographers, screening centre’s, and
countries [117–122]. A disadvantage of compression is that many women complain about
discomfort and pain, which might influence their participation in screening [123–125]. A
reduction in compression force has therefore been suggested to encourage screening attend-
ance [126].
Although mammography systems display the compression force applied by the compres-
sion paddle to the breast, it is the pressure, which is defined as the compression force divided
by the contact area between breast and compression paddle, that determines how much the
tissue is compressed. It is therefore likely that the pain experienced by women undergo-
ing mammography is more related to pressure than to force. The same force applied to a
small or a large breast leads to different pressures. Pressure depends on the force and the
contact area between the breast and the paddle, which depends on the breast size and the
deformation and shape changes of the breast during compression. In case of a large contact
area, the force is distributed over a larger area, leading to a lower pressure (force per unit
area) compared to a small area. In a study by de Groot et al. [127] the force-standardised
compression protocol was replaced by a pressure-standardised protocol using a recently
developed paddle [128]. It was found that pain was reduced with pressure standardisation,
while average glandular dose remained unchanged.
While it is widely accepted that firm breast compression is needed to ensure acceptable im-
age quality, guidelines remain vague about how much compression should be applied [129]
and a quantitative parameter indicating the amount of compression is not used. Con-
sequently, little is known about the relationship between the amount of breast compression
and breast cancer detectability. Furthermore, it has been reported that too much compres-
sion, as applied during spot compression, can lead to dissolving of suspicious densities in
some cases [130–132]. Therefore, this retrospective study aims to investigate if the level
of breast compression can impact screening performance, using pressure to characterise the
level of compression.
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6.2 Materials and Methods
6.2.1 Screening Data
In this retrospective study, mammograms that were acquired in the Dutch breast cancer
screening program are used. In this population based program, women between 50 and
75 years of age are invited for a screening exam every two years. A consecutive series of
mammograms acquired in one screening unit were collected. Raw mammograms acquired
in this unit were archived between 2003-2012, except for a four month period in 2009 due
to a technical issue. The images of the 135,640 available examinations were acquired on
Lorad Selenia systems (Hologic, Inc., Danbury, CT, USA). Of these examinations, 113,956
examinations have been previously reported [133]. Cancer status information was obtained
from the screening registration system and the Netherlands Cancer Registry. Written in-
formed consent was not required for this study as women automatically consent to the use
of their anonymised data for scientific purposes by participating in screening unless they
object. Data of participants who objected to the use of their data was removed.
In this screening program, mediolateral oblique (MLO) and craniocaudal (CC) view images
were always acquired at the first screening. However, during the study period, screening
guidelines recommended that during subsequent rounds CC images be acquired only when
the technician detected a possible abnormality or when high breast density was present.
Therefore, CC view images are available only in about 60% of the exams. There are sys-
tematic differences between MLO and CC views in force and pressure. Therefore, to ex-
clude these differences and to prevent a bias towards abnormal and dense breasts we used
only MLO view images in this study.
Screen-detected cancers or true positives (TP) are defined as the cancers diagnosed after a
recall of a woman for additional diagnostic tests. Interval cancers or false negative (FN) ex-
aminations are defined as cancers that were found within 24 months after a negative screen-
ing mammogram and before the next screening exam. False positive (FP) examinations are
exams of women recalled for additional tests in which no breast cancer was diagnosed and
true negatives (TN) are exams that did not lead to a recall and after which no breast cancer
was diagnosed within 24 months before the attendance to another screening round.
6.2.2 Image Analysis
Compression pressure was determined retrospectively using a research version of the soft-
ware Volpara (v1.5.0, Volpara Health Technologies, Wellington, New Zealand). The al-
gorithm determines the contact area between the breast and the compression paddle by
image analysis as described in [102]. The contact area measured with Volpara has been
validated against manual segmentations from video images [134]. Pressure is computed by
taking the compression force measurement from the imaging device, which is stored in the
image header, and dividing it by the estimated contact area. Volpara software was also used
to determine breast volume and dense tissue volume, which were used to compute percent
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dense volume. For the true negative exams and bilateral findings, the values obtained for
the left and right MLO views were averaged. For all other exams the values for the side
with the finding or cancer was used.
6.2.3 Data analysis
The relationships between breast volume and force and pressure were investigated using
heatmaps. The pressure measurements were used to divide the dataset into quintiles of
increasing pressure. Within the five groups the following performance measures were de-
termined: recall rate, false positive rate, screen-detected breast cancer rate, specificity, and
positive predictive value as done in a previous publication [133]. Additionally, the interval
cancer rate, the program sensitivity (number of screen-detected cancers divided by the sum
of screen-detected cancers and interval cancers diagnosed before the next screening round)
and 12 month sensitivity (program sensitivity using only the interval cancers diagnosed
within 12 months after examination) were determined. The 12 month sensitivity may be
used to translate results to the context of an annual screening program.
Many women in the data set had more than one screening examination. To account for cor-
relation between examinations of the same woman, we used generalized estimating equa-
tions (GEE) using the ’independence’ correlation structure. As it is known that the sens-
itivity of mammography is lower in women with higher breast density [29, 31, 92], breast
volume and percent dense volume were included in the models to adjust for their potentially
confounding effect. Breast volume and density were transformed using the natural logar-
ithm to obtain data which approximated normal distributions. Pair-wise testing was applied
to assess differences between the groups on the sensitivity and specificity measurements.
Correction for multiple testing was applied using the Tukey method and a p-value below
0.05 was considered significant. GEE was used for each performance measure separately.
For each pressure group, the distribution of the different cancer types and their detection at
screening or as interval cancers, using the non-corrected data, was also investigated. For
this, the following categories were used: ductal carcinoma in situ (DCIS), invasive ductal
carcinoma (IDC), invasive lobular carcinoma (ILC), ’other’ and unknown.
Statistical analysis was performed using R version 3.3.1.
6.3 Results
In total 135,640 examinations were available. Excluding examinations with unknown screen-
ing outcome (N=72), examinations without a breast density, contact area or force measure-
ment available (N=2,673), and interval cancers diagnosed more than 24 months after the
examination (N=119), a total of 132,776 examinations were included in the analysis.
To stratify the exams into five groups of equal size, thresholds on the pressure estimates
were applied at 7.7, 9.3, 10.8, and 13.0 kPa, resulting in the mean breast volumes, percent
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breast densities, forces and pressures listed in Table 6.1. As expected, it can be seen that
increasing compression pressure correlated with decreasing breast volume and increasing
breast density, and force.
Group 1 Group 2 Group 3 Group 4 Group 5
Number examinations 26,490 26,617 26,539 26,549 26,581
Mean breast volume (cm3) 1511 1135 928 755 540
Mean percent dense volume (%) 5.7 6.6 7.5 8.4 10.7
Mean force (N) 112.6 121.5 125.9 130.7 138.9
Mean pressure (kPa) 6.6 8.5 10.0 11.8 15.6
Table 6.1: Number of screening examinations in each pressure group, and mean breast volumes,
breast densities, forces and pressures in each group.
Heatmaps showing the variations in force and pressure with breast volume are shown in
Figure 6.1, illustrating the difference between force and pressure. The horizontal lines in
the pressure distribution mark the thresholds used to form the quintiles. It is observed that
breasts of the same size are imaged using a wide range of forces. At the same time a trend
is indicating that larger breast are imaged with higher forces, so some adjustment to the
individual breast takes place. The pressure distribution shows, however, that the very large
breasts are imaged with a low pressure and therefore most of these cases are in the first
pressure category. Additionally, it is observed that the first pressure group contains the en-
tire range of breast sizes, while extremely high compression is mainly a problem for small
breasts. This is due to medium and high forces, as shown in the left heat map, being dis-
tributed over a small contact area, leading to high pressure.
Table 6.2 gives an overview of the screening outcomes for the complete cohort stratified
by the five compression pressure groups. Screening performance measures are displayed in
Table 6.3. Results suggest that at high compression pressure, sensitivity is reduced.
Results from the GEE models are shown in Table 6.4, confirming the decrease in sensitivity
at high pressure observed in the unadjusted data. There is a statistically significant differ-
ence in the 12 month sensitivity between the third and the fifth group (p=0.0343). Even
though this is the only significant difference between groups on the sensitivity measure-
ments, a considerable difference can be observed between the first three pressure groups
and the last two pressure groups. Results also show a trend that women with mammograms
in the lowest pressure group are recalled more often. This leads to a higher false positive
rate, and lower specificity and positive predictive value. The specificity was found to be
significantly lower in the first group compared to the second (p=0.0002), third (p=0.0007)
and fourth (p=0.0021) group. The 12 month sensitivity and the specificity are displayed in
Figure 6.2 with and without correction for confounders.
In Figure 6.3, the distribution of DCIS, IDC, ILC and the remaining other types cancers
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for the different pressure categories is given. The distribution is shown separately for all
cancers, screen-detected cancers and interval cancers. As expected, only few DCIS cases
are found among the interval cancers. The proportion of lobular and other types of cancers
is relatively high for the interval cancers in the highest pressure group. Because of the low
number of cancers in each subgroup, statistical analysis of subgroup differences was not
performed.
Figure 6.1: Measurements of force and pressure in relation to the breast volume. The colour code
represents the number of exams in each bin. The horizontal lines in the right figure indicate the
thresholds used to get the five pressure groups.
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Figure 6.2: Measurements of 12 month sensitivity and specificity of the five pressure groups of un-
adjusted data (squares) and after adjustment with GEE for multiple screening rounds, breast volume
and breast density including 95% CI (circles). Statistically significant differences between pairs of
groups of the GEE adjusted data are indicated.
Figure 6.3: Cancer type distribution for the five pressure categories for all, screen-detected, and
interval cancers. Because of the low number of cancers in each subgroup, statistical analysis of
subgroup differences was not performed. The number of cancers for the five pressure groups, re-
spectively, is 214, 212, 236, 217, and 223 for the all cancers together, 177, 164, 188, 152 and 152
for the screen-detected cancers and 37, 48, 48, 65 and 71 for the interval cancers.
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6.4 Discussion
Given the reasons for using mechanical breast compression during mammographic imaging
(reduction of tissue superposition, scatter, dose, possibility of motion, among other image
quality-related benefits), it was expected that screening outcomes would be negatively im-
pacted if the compression pressure applied was too low, as found in our results. As could
have been foreseen, applying insufficient compression lowers the specificity of mammo-
graphy, perhaps due to a lack of minimisation of tissue superposition. In this context, it
should be highlighted that the overall compression force, and therefore pressure, is rather
high in the Netherlands compared to other countries [117, 118, 120]. Hence, the loss of
performance due to insufficient compression may be a more common issue in general than
that found in this study. The finding demonstrates that an adequate level of compression is
necessary to obtain good image quality and achieve a low recall rate, and stresses the need
for techniques to apply compression at the right level. Though one should be careful with
extending our conclusions to other populations, since screening policies vary from country
to country, e.g. recall rates are higher in the US than in Europe, we note that our study
sample is representative for breast cancer screening in Europe where low recall rates, as in
our study, are common [135].
Though some reports were published about reduced visibility of a subset of tumours in spot
compression [130–132], which typically are made with stronger compression, it was not
a priori expected that high compression levels in screening mammography would have a
large negative impact on screening outcomes. However, it seems that applying a higher
than needed compression actually has a stronger negative effect on lesion visibility than ap-
plying insufficient compression, even when correcting for the confounding effects of breast
density and volume, resulting in a lower sensitivity. Even though the difference in sensit-
ivity did not reach statistical significance when corrected for confounding factors, except
for the 12 month sensitivity between group 3 and group 5, the reduction was considerably
larger than that suffered due to applying low compression.
It is not straightforward to identify the underlying cause for reduced sensitivity at high
compression levels. This reduction in sensitivity could be due to either malignancies not
being seen or being seen but mischaracterised, or due to both types of errors. Reduced
visibility of certain tumours under high compression might be due to their composition. It
can be reasoned that softer tumours may become less conspicuous with high compression,
because the cancer tissue may spread out and lose contrast. Another reason could be that
lesion types that are detected because of architectural changes of the breast parenchyma are
less conspicuous under lower and higher pressure. This is supported by the distribution of
ILC over the five groups. Although, it is hard to say with the given data whether a specific
type of cancer is more often missed because of too low or too high pressure. The different
cancer types should be kept in mind when investigating the relationship between pressure
and screening performance in future studies, with other, perhaps larger, data sets. In terms
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of mischaracterisation, vascularisation might play a role. Since invasive cancers are often
highly vascularised, strong compression may lead to a reduction in blood flow [136, 137],
leading to both a decrease in contrast and a reduction in the perceived suspiciousness of the
finding, causing misinterpretation of its probability of malignancy [45].
The force and the pressure distributions were displayed in relation to the breast volume.
The first pressure group contains the entire range of breast volumes. For women with small
breasts, the low pressure is caused by a low force. For larger breasts, the contact area is
larger so that even a medium or high force leads to a low pressure. An extremely high
pressure is only observed for small breasts and is caused by too much force. Therefore, a
compression recommendation based on force cannot solve the over-compression of small
breasts and the under-compression of large breasts, as the force measure is independent
of the individual breast characteristics. On the other hand, a pressure guided compression
could prevent extreme compressions of small breasts and too low compressions of larger
breasts, as the pressure measurement depends on the breast size, shape and stiffness.
One limitation of this study is that in MLO views, the pectoral muscle is included in the
compressed tissue. Therefore, a portion of the compression force is absorbed by the muscle
and not by the breast. Dustler et al. [138] found that the resulting pressure distribution
during breast compression is not uniform, and that in some cases the pressure is highest in
the pectoral muscle. Hence, estimating the pressure to the entire breast as a single value
based on the overall force and area might not reflect the pressure sustained by the overall
breast tissue, especially by the area where the missed lesions are located in the cases of
reduced sensitivity. However, if the lesions were missed due to a decrease in blood flow
into the breast tissue, perhaps the application of maximal pressure at the posterior border of
the breast, against the muscle, is enough to have this effect.
Another limitation of this study is that CC views, and the per-view lesion sensitivity and
specificity, were not included due to the fact that CC views were not acquired in a substan-
tial portion of the screening exams at the time of data acquisition. In essence, this means
that the presented results are based on the pressure applied for the acquisition of the MLO
view only, while the screening outcomes are calculated based on the whole exam, which in
the majority of exams also included CC views. To investigate the effect of compression in
CC view images on the screening performance, a data set for which both views are avail-
able should be used. Finally, although this is a data set spanning many years and therefore
includes exams in which various radiographers performed the acquisitions and various radi-
ologists interpreted them, it is still a single-site study with all images acquired with a single
mammographic system model. It is not expected, however, that compressions performed
with other systems should have an impact on breast compression pressure and its relation-
ship to screening outcomes.
Our retrospective analysis is performed with mammograms acquired in screening practice.
Although the results and conclusions are based on a large sample of cases, evidence for our
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findings would become stronger if mammograms of individual women could be obtained
who were repeatedly imaged with different compressions. Since such evidence is currently
lacking, we feel that it would not be appropriate to recommend an optimal pressure range
based on this study alone. Further studies are needed to confirm our findings, ideally in-
cluding a study with repeated imaging at different predefined pressures, to investigate lesion
visibility as function of pressure.
In conclusion, this study shows a relation between the applied pressure and the perform-
ance of screening mammography even when taking into account confounding effects. The
recall rate, false positive rate, and specificity were affected negatively in the compression
category with the lowest pressure, while the sensitivity was reduced in the categories with
high pressure. Since this is the first time this is reported, more research to confirm poten-
tial effects of pressure on performance is necessary because more attention to a meaningful
standardisation of compression levels might improve mammography in the future.
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Breast cancer is the most common cancer diagnosis in women [1]. Early detection is cru-
cial to reduce breast cancer mortality. Therefore, many countries have implemented breast
cancer screening programs, in which asymptomatic women of a certain age are screened
regularly to find breast cancer before it becomes palpable and symptomatic. Most women
are only screened with mammography during their life. Mammography has, however, its
limitations. Fibroglandular tissue and cancer tissue have the same attenuation for X-rays
making it hard to distinguish them on mammograms. Hence, it is possible that a cancer is
masked in dense tissue structures and is therefore not detected with mammography. This
leads to cancers that are detected outside the screening programs in between two screening
rounds. These cancers, which are called interval cancers, are often diagnosed in a later
stage with a worse prognosis [16–18]. To reduce the number of interval cancers screening
should be improved. This may be accomplished by introducing personalised screening.
In personalised screening, the risk of development of breast cancer and the risk of missing a
cancer with mammography is determined and subsequently used to offer individual women
a screening procedure that best fits to their needs. Personalised screening can be implemen-
ted in different ways: by offering examinations at different time intervals, depending on
the risk of developing breast cancer, by offering screening with different modalities, or by
offering additional imaging to mammography in case of a decreased sensitivity with mam-
mography.
This thesis focuses on mammographic breast density and its potential to be used as strati-
fication tool for personalised breast cancer screening.
In Chapter 2, the performance of the Dutch breast cancer screening program is studied
in relation to four breast density categories. We used the four volumetric density groups
(VDG) obtained from mammograms by processing with the automated software method
Volpara. It is observed that the risk of developing breast cancer increases with an increase
in breast density (breast cancer rates of 4.6, 8.3, 9.4, 11.2 per 1000 women screened for the
four groups respectively). At the same time, only a small increase is observed in the screen-
detected cancer rate throughout the second to fourth density category (4.0, 6.4, 6.6 and 6.8
screen-detected cancers per 1000 women screened for the four groups, respectively), while
strong a increase is observed in the number of interval cancers with increasing breast dens-
ity (interval cancer rate of 0.7, 1.9, 2.9 and 4.4 per 1000 examinations). Together this leads
to a substantial drop in screening program sensitivity (85.7%, 77.6%, 69.5%, 61.0%) when
breast density increases, despite the higher recall rates observed with increasing breast dens-
ity. Thus, women with dense breasts do not only have an increased breast cancer risk but
also an increased risk that the cancer is not detected with mammography within the national
breast cancer screening program.
In the past years, mammographic breast density has become a major issue in breast screen-
ing practices the United States. Many states passed legislation that requires radiologists
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to inform women about their breast density and the associated risk for breast cancer and
masking. In this context, the ACR BI-RADS density categories 1 and 2 (4th edition) or a
and b (5th edition) are considered non-dense, while women with a BI-RADS density cat-
egory 3 or 4 (4th edition) or c or d (5th edition) are informed that they have dense breasts.
Additional imaging with ultrasound in screening exams of women with dense breasts is
reimbursed in some states [139]. To use such a categorisation into four or two categories
to personalise screening, it is necessary to have a consistent categorisation, also over time.
Otherwise, women and clinicians might lose confidence in the stratification process. This
is acknowledged in a review paper, where concerns are raised that radiologists’ variability
of BI-RADS density assessments over time may lead to inconsistent information in man-
dated communications about elevated breast cancer risk and supplemental screening [62].
Several studies show that the BI-RADS categories are prone to inter-reader and intra-reader
variability [39–42]. The use of automated software would solve the problem of intra-reader
variability as the algorithm always gives the same result.
In the study described in Chapter 3, breast density assessment of serial mammogram pairs
is investigated and the results of four readers are compared to the automated density assess-
ment with Volpara. First of all, it was found that when using a binary classification into
non-dense and dense breasts, most pairs get assigned to the same category. The expected
decrease of breast density with age is observed in this study as well, about 6-10% of the
women switch density categories from dense to non-dense in subsequent screenings. A
change in category from non-dense to dense is not expected frequently because this does
not fit with the regular biological pattern of changes in the breast. With software, less cat-
egory changes into the dense category are observed compared to the human assessment. In
screening practice, consecutive mammograms are usually not read by the same radiologist.
Therefore, to measure consistency over time of human assessment of breast density, in the
analysis of our reader study data, each exam was randomly assigned to one of the readers
to simulate screening practice. It was found that the software has significantly less cat-
egory changes and a higher agreement between the two mammograms than human readers.
Therefore, software based assessment may be preferred when estimating breast density for
breast density stratified screening.
With the introduction of digital mammography, it became possible to save more inform-
ation than the X-ray image. Nowadays, compression settings, and tube and filter mater-
ial information are stored together with the pixel data. Using an internal calibration and
raw image data it is possible to accurately determine the volume of fibroglandular tis-
sue in the breast [45, 46]. This method is implemented in the Volpara software. Thus,
from the 2-dimensional mammographic image a 3-dimensional quantity is obtained. To
evaluate the performance of volumetric breast density assessment algorithms, mammo-
graphic breast density is compared to breast density measured with MRI. These comparis-
ons show, that with the internal calibration, breast density is underestimated in extremely
511786-L-bw-Holland
Processed on: 2-8-2017 PDF page: 108
100 Summary and discussion
dense breasts [51–53]. This is caused by the fact that a pixel with the least amount of
fibroglandular tissue is used as a reference. When the breast is non-dense, it can be as-
sumed that this pixel belongs to the projection of only fatty tissue, but in an extremely
dense breast, this assumption is not valid anymore. As a consequence, the fibroglandular
tissue volume and subsequently percent density are underestimated. In Chapter 4, a novel
method is presented to improve breast density estimates for dense breasts. In case the breast
is non-dense, the standard method is used, that has been validated many times. The new
method assumes that the breast is very dense. For this reason, the new method can not be
applied to non-dense breasts and it is necessary to use a combination of methods to obtain
a breast density estimate for all types of breasts. The best results were obtained with the
combination of methods. It is noted that the internal calibration approach used in our work
is not the only method to obtain a volumetric breast density estimate for the mammogram.
But, compared to other methods our approach has the advantage that only a mammogram
with the ’raw’ pixel data is required to apply the method. Other methods require that a
phantom is placed next to the breast during mammogram acquisition or a complex calibra-
tion of the imaging unit [78, 79, 99].
Chapter 2 shows that the sensitivity of mammography decreases with an increase in breast
density and that more interval cancers were found at higher densities than at lower densities.
This effect is explained by masking. Fibroglandular tissue and cancerous tissue have the
same attenuation for X-rays. Hence, both types of tissue have the same appearance on the
mammogram. In case of a dense breast, it is then more difficult or not possible to detect the
cancer in the mammogram. The cancer is obscured by dense tissue structures and masks
its true nature. The explanation that interval cancers are also found in non-dense breasts
is given by the definition of interval cancers. Interval cancers are defined as the cancers
that are found after a negative screening round and before the next scheduled examination.
This definition does not take into account the presence of the cancer at the last examination.
Therefore, it is also possible that the cancer is a fast growing lesion that was not present
in the breast at the time of screening and was therefore not detectable by the radiologist.
These cancers are called true interval cancers. To decide whether the interval cancer is a
true interval cancer or not, it is necessary to compare the diagnostic mammogram with the
last screening mammogram. Studies have shown that many interval cancers are visible on
the screening mammogram in retrospect [19–21]. The problem is, however, that not all
cancers that are visible on the screening mammogram in retrospect are masked cancers. It
is also possible that the lesion was simply missed by the radiologist. Furthermore, it is also
possible that the lesion is already present in the breast and that there are no signs of ma-
lignancy in the mammogram, as it is completely impossible to distinguish cancerous from
fibroglandular tissue.
Although the presence of breast density is related to masking, the relation is likely to be
more complex than a simple dependence on the amount of density. Also, the distribution
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of dense tissue may play a role, which is reflected in the fifth BI-RADS definition. In
Chapter 5, it is investigated to which extent volumetric breast density can be used to predict
an interval cancer as a proxy for masking risk. This was done with the interval cancers
that are detected within 12 months after the negative screening mammogram, to increase
the likelihood that the lesion was already present in the breast at the time of screening. It
was a limitation of our study that the diagnostic mammograms were not available to clas-
sify all interval cancers as true interval cancers or as undetected cancers. Next to percent
dense volume, two other automated measurements are investigated to predict interval can-
cers. These measurements make use of density maps. A density map represents the amount
of fibroglandular tissue for each pixel location. The study shows that a simple measure-
ment such as the percentage breast area that is covered with a fibroglandular tissue column
of more than 1cm might be a better masking risk predictor than percent dense volume.
Moreover, a dense tissue masking model is presented. The model takes into account the dis-
tribution of tumour diameters of screen detected cancers and a cancer location probability
map. With the model, it is acknowledged that the risk of masking increases with increasing
(local) breast density while it takes into account that the risk of masking decreases with
increasing cancer size. The cancer location probability distribution considers that a cancer
is more likely to be present in the interior region than in the breast periphery. Unfortu-
nately, we found that though the masking model is more sophisticated than thresholding of
the density map, the performance remains behind the thresholding method. All automated
methods show a better performance in predicting interval cancers than an experienced radi-
ologist did with thresholding at the BI-RADS b/c transition.
The breast is compressed between the compression paddle and the detector during mammo-
gram acquisition to reduce dose, tissue superposition, X-ray scatter and the possibility of
motion and therefore motion artefacts [113–116]. Today, compression is often force con-
trolled. The force applied is independent of breast size and many women, especially those
with small breasts, complain about pain during the acquisition. A better measurement of
compression might be pressure, defined as force divided by contact area. The contact area
is the area of the breast that is in contact with the compression paddle. In Chapter 6, the
screening program performance is evaluated in relation to pressure. The data is divided
into five groups of equal size depending on the pressure estimate of the MLO view with
a finding. Generalized estimating equations are used to determine the screening perform-
ance measures and to account for differences in breast volume and breast density within
the groups. It is found that the women in the first pressure category are more often re-
called. In this group also a higher false positive rate and a lower positive predictive value
was observed. These results support the necessity of sufficient compression to guarantee
image quality and avoid unnecessary recalls. On the other hand, it is found that too much
compression is contra productive for the screening program performance. The sensitivity
is lowest in the two groups with highest pressure, e.g. more interval cancers are found in
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these groups. Based on these results, which should be confirmed by other studies, one could
consider to change recommendations in screening. Instead of applying approximately the
same force to all breasts, compression should be adjusted to the individual breast volume
and composition with a pressure measurement.
Breast density: Are we ready for breast density stratified screening?
In the previous chapters, we have looked at different aspects of breast density, how to meas-
ure breast density and how it would perform when used for stratification. In this last section,
we will discuss whether personalised screening is feasible within the next years in Europe
and what needs to be done to implement breast density stratified screening.
The idea to personalise breast cancer screening based on breast density arises from the fact
that women with dense breasts have a higher masking risk and a higher breast cancer risk
compared to women with non-dense breasts as seen in Chapter 2.
The first problem that comes up when introducing personalised screening is the missing
agreed definition of breast density that is suited for high volume stratification. Different
breast density measurements were used in the past and they all show the increase in breast
cancer risk with increasing breast density. So far it remains unclear which breast dens-
ity measurement should be used for risk assessment. In clinical practice, the BI-RADS
categories are commonly used. The problem with BI-RADS categories is the large inter-
and intra-reader variability. The use of automated software is a way to remove intra-reader
variability and to make personalised screening procedures objective and predictable. To
eliminate ’inter-reader’ variability it is necessary to choose one algorithm.
For a long time, the semi-automated software Cumulus [55] was considered the gold stand-
ard and a strong relationship between Cumulus density measurements and breast cancer risk
were observed. The problem with Cumulus is, however, the fact that a percentage dense
area is measured, which is not projection invariant, and that Cumulus is semi-automatic,
so it requires still some user input which makes it labour intensive and prone to intra- and
inter-reader variabilities. Hence, Cumulus is less suited for screening where fast, consistent
and objective measurements of breast density are needed. Therefore, automated volumetric
measurements are a better option. But, even when deciding to use volumetric breast density,
a wide palette of options and algorithms is available. Starting by algorithms that use an in-
ternal calibration [45–47], like the commercially available programs Volpara and Quantra,
and continuing with algorithms that require a phantom to be placed next to the breast [99]
or a complex calibration of the mammographic system [78, 79]. Even more options are
described in the review of He et al. [54].
When a method for breast density measurement has been chosen, it still remains open how
to use these measurements for risk stratification. Is percentage dense volume the best meas-
ure, or should the fibroglandular tissue volume and breast volume be combined in a different
way? Should we estimate the risk with continuous measurements, should we use quartiles,
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or should we use some other thresholds, like the ones used to get the VDG categories out
of the percent density measurement? Should the density and risk be estimated based on
images of the first screening round or with each screening round?
To answer these questions researchers are actively looking into these issues. In the study by
Eng et al. [24], six breast density algorithms were used to estimate the breast cancer risk.
Commercially available percent dense volume estimations were compared to BI-RADS and
Cumulus. It was found that the highest risk predictions were found with automated meas-
urements of volumetric percent density, in particular with Volpara. In the study by Wanders
et al. [140], different combinations of Volpara results were used to estimate the breast can-
cer risk (using all cancers within the database) and masking risk (using the interval cancers).
It was found that the fibroglandular tissue volume gave higher risk estimations than percent
dense volume when estimating the breast cancer risk, while risk predictions for interval can-
cers were highest when using percent dense volume. Therefore, the density measurement
used for stratification could be different for the different risk estimations. As personalised
screening aims for a reduction of the interval cancer rate and for finding cancers that are
otherwise missed with mammography, percent dense volume could be preferred for risk
estimations and stratification.
A difference between the studies of Eng and Wanders is the evaluated examination. Eng et
al. made use of the last available mammogram before the cancer diagnosis, while Wanders
et al. used the first digital available mammogram. Given these results, it is not clear on
which measurement risk stratification should be based. When using the first available mam-
mogram, the breast cancer risk is only estimated once. In that case, the entire screening pro-
cedure is determined based on one estimate. As the density decreases with time, also the
risk of masking decreases as there is less fibroglandular tissue to obscure the lesion. There-
fore, taking the most recent mammogram to determine masking risk is a logical choice as
the screening procedure should be adjusted to the risk at the time of screening. This way of
implementation has also its drawbacks. Variability over time is possible, which could lead
to confidence loss in the stratification process. Our study in Chapter 3 is of relevance in this
respect, as it shows that serial mammograms are assigned to the same density class more
often by the Volpara software than by human readers.
In the study by Eng et al., only the four point categorisation VDG was used, while Wanders
et al. presented results for VDG and the continuous percent dense volume measurement.
The underestimation of percent density in extremely dense breasts, that was discussed in
Chapter 4, is not a problem when using VDG, as the thresholds to form the groups are
chosen in such a way that the breasts with underestimation are still in the highest density
category. However, when using continuous measurements like in Wanders et al., the risk
estimation might benefit from the improvement in fibroglandular tissue volume estimation
as obtained with the novel method proposed in Chapter 4.
Though breast density shows a higher correlation with breast cancer risk and masking risk,
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it is likely that the risk of masking is more complex and that a measurement of percent dense
volume is not enough. We showed that other measurements perform better in the differen-
tiation of interval cancers from true negative screening mammograms and that these might
be preferably for stratification in a personalised screening program (Chapter 5). Further-
more, combining texture measurements with breast density estimations can improve risk
estimations [141].
The well established fact of decreasing sensitivity of screening with increasing breast dens-
ity has already led to breast density legislation that mandates the disclosure of breast dens-
ity to women undergoing mammography screening in the United States. In case of dense
breasts, increased breast cancer risk and masking risk as well as supplemental screening op-
tions are communicated with the client. In some states, additional imaging is reimbursed.
But, laws vary from state to state leading to different implications for the women [142].
Results of the changing screening practice in the U.S. are starting to appear in the scientific
literature and it is likely that these will have an impact on screening policies elsewhere.
Also in Europe, the use of alternative screening modalities such as breast ultrasound, breast
tomosynthesis, and breast MRI is increasing.
A current problem is that the evidence for cost-effectiveness and benefits of breast density
stratified screening is not that clear. The review of Melnikow et al. [62] states a need for
well-designed, long-term and prospective studies. There are studies that investigate the be-
nefit of ultrasound or MRI after a negative mammogram [58–60]. The problem with these
studies is that only the cancer rate and the false positive rate with and without intervention
are measured. Additional imaging increases the cancer rate at the cost of an increase in
the false positive rate. It remains open how breast cancer mortality and interval cancer rate
are affected. A step in the right direction is the DENSE trial [61], which is ongoing in the
Dutch breast cancer screening program. In the randomised controlled trial, MRI is offered
to women with extremely dense breasts (VDG 4). The primary outcome measure is the
difference in proportion of interval cancers. First results of this trial are expected within the
next years.
To conclude, to introduce breast density stratified screening in Europe, more evidence is
needed that additional imaging improves the patient outcome with low additional burden
for the screening population at low costs. As interval cancers are usually detected in a later
stage, a reduction of interval cancers could be used as intermediate measure. Furthermore,
the research community has to agree on acceptable ways to measure breast density, breast
cancer risk and masking risks. Last, we have to think carefully about patient communic-
ation. It should be clear how stratification is performed and which implications it has. In
the end, personalised screening should improve the current screening regime. The benefits
should outbalance the harms.
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Borstkanker is de meest voorkomende kanker bij vrouwen en de vroege opsporing van
borstkanker in het bevolkingsonderzoek verhoogt de kans op overleving. In dit bevolkings-
onderzoek krijgen asymptomatische vrouwen wanneer ze in een bepaalde leeftijdcategorie
zijn regelmatig een mammografisch onderzoek aangeboden. In de meeste landen begint
screening rond de leeftijd van 50 jaar, en de laatste uitnodiging om aan het bevolkingson-
derzoek deel te nemen wordt ontvangen door vrouwen met een leeftijd van 70 of 75 jaar. In
deze leeftijdgroep is de kans op het ontwikkelen van borstkanker het hoogst. In Nederland
krijgen vrouwen iedere twee jaar een mammogram aangeboden wanneer ze tussen 50 en 75
jaar oud zijn.
Vele studies hebben de effectiviteit van borstkankerscreening aangetoond, maar er zijn niet
alleen voordelen. Naast het vroegtijdig opsporen van kanker bestaat er ook de kans op vals
alarm, zogenaamde fout-positieve uitslagen. Daarnaast betekent een negatieve uitslag niet
dat er geen kanker aanwezig is in de borst. Ruim 16-33% van de borstkankers wordt bui-
ten het bevolkingsonderzoek tussen twee screeningsrondes gediagnosticeerd. Deze kankers
worden intervalkankers genoemd en zijn in sommige gevallen al zichtbaar op het voor-
gaande mammogram.
In het huidige programma krijgen alle vrouwen hetzelfde onderzoek aangeboden: een mam-
mogram. Het risico op het ontwikkelen van borstkanker is echter niet voor alle vrouwen
hetzelfde. Het borstkankerrisico hangt af van vele factoren. De verschillende risicofacto-
ren zouden gebruikt kunnen worden voor een individueel risicoprofiel dat vervolgens voor
een ’screening op maat’ gebruikt kan worden. Afhankelijk van het risico op borstkanker
en het risico dat de kanker met een bepaalde techniek gemist wordt, kan dan de screening
geı¨ndividualiseerd worden door verschillende vrouwen verschillende screeningstechnieken
met verschillende periodes tussen de screeningsrondes aan te bieden.
Een van de borstkankerrisicofactoren is borstdichtheid. De borstdichtheid is een maat voor
de hoeveelheid klierweefsel in de borst. Tegenwoordig, in de tijd van de digitale mam-
mografie, is het mogelijk het klierweefselvolume te berekenen door een computer. Samen
met een berekening van het borstvolume kan dan het percentage klierweefsel geschat wor-
den. In de klinische praktijk wordt meestal gebruik gemaakt van een dichtheidsschatting
van een radioloog. Met behulp van de ACR BI-RADS atlas bepaalt de radioloog tot welke
van de vier mogelijke dichtheidscategoriee¨n het mammogram hoort. Het probleem met de
schattingen van radiologen is echter dat de categoriee¨n verschillen wanneer verschillende
radiologen hetzelfde mammogram hebben beoordeeld, en dat ook de categoriee¨n kunnen
verschillen wanneer dezelfde persoon een beeld op verschillende tijdstippen heeft beoor-
deeld. Door de dichtheidsschatting door een computer te gebruiken is het mogelijk de eer-
der genoemde inter- en intralezervariabiliteit te voorkomen. Om de automatische schatting
met de BI-RADS categoriee¨n te kunnen vergelijken, is het nodig om van het klierweef-
selpercentage over te gaan naar een categorische maat. Dit klierweefselpercentage onder-
verdeeld in vier klassen wordt uitgedrukt als ’Volumetric Density Grade’ (VDG). VDG is
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een dichtheidsschaal die gebaseerd is op het percentage klierweefsel gemeten met Volpara,
een commercieel beschikbaar softwarepakket. Studies hebben laten zien dat de dichtheids-
schatting van een radioloog met BI-RADS en VDG goed correleren.
Een maat om de prestaties van borstkankerdetectie in het bevolkingsonderzoek te meten
is sensitiviteit; het percentage borstkankers dat binnen screening wordt ontdekt. In hoofd-
stuk 2 lieten we zien dat de sensitiviteit afhangt van de borstdichtheid. Hoe hoger het
klierweefselpercentage, des te groter de kans dat een tumor buiten het bevolkingsonder-
zoek wordt ontdekt. Vrouwen met een hoge borstdichtheid hebben dus naast een verhoogd
risico op het ontwikkelen van borstkanker ook een verhoogd risico op het niet ontdekken
van de kanker binnen het bevolkingsonderzoek, in vergelijking met vrouwen met een lage
borstdichtheid. Ook werden vrouwen met veel klierweefsel vaker doorverwezen en hebben
vaker een fout-positieve uitslag.
De discussie over lage sensitiviteit ten gevolge van hoge borstdichtheid heeft in de Vere-
nigde Staten (VS) tot wetgeving geleid, de zogenoemde ’breast density notification laws’.
In veel staten in de VS worden vrouwen over hun borstdichtheid en de daarmee verbonden
risico’s geı¨nformeerd en in sommige staten krijgen vrouwen additionele beeldgeving aan-
geboden. Vaak wordt er alleen onderscheid gemaakt tussen een lage en hoge borstdichtheid
(BI-RADS a/b versus c/d, VDG 1/2 versus 3/4). Op deze manier kan borstkankerscreening
individueel worden afgestemd. Afhankelijk van het individuele borstkankerrisico en het
risico op een intervalkanker kan de mammografie door een andere modaliteit vervangen
worden of wordt er additionele beeldvorming aangeboden zoals tomosynthese, echografie
of MRI.
In hoofdstuk 3 hebben we gekeken hoe de borstdichtheidsschatting zich gedraagt naarmate
de leeftijd hoger wordt. Dit is van belang wanneer de borstdichtheid wordt gebruikt om
te stratificeren naar individuele screeningsschema’s, omdat afwijkende adviezen tussen de
tweejaarlijkse screeningsronden mogelijk kunnen leiden tot onzekerheid en een verminderd
vertrouwen in de stratificatie. Om hier inzicht te geven in de eventueel veranderende borst-
dichtheid van vrouwen hebben we van 500 vrouwen borstdichtheid van twee opeenvolgende
screening mammogrammen geschat. Dit werd zowel met geautomatiseerd software gedaan
(VDG) als ook door radiologen die de BI-RADS classificatie gebruikten. We hebben met dit
onderzoek laten zien, dat in meer dan 85% van de gevallen opeenvolgende screeningsmam-
mogrammen in dezelfde borstdichtheidscategorie terecht kwamen (laag versus hoog) wan-
neer e´e´n radioloog beide screeningsrondes beoordeelde. Maar in de praktijk worden binnen
het bevolkingsonderzoek verschillende screeningsrondes vaak door verschillende radiolo-
gen beoordeeld. Om die reden hebben we een situatie gesimuleerd waarin de borstdichtheid
van iedere screeningsronde van een willekeurige radioloog visueel geschat werd. Het blijkt
dat in deze situatie twee opeenvolgende screeningsrondes vaker in dezelfde dichtheidsgroep
terecht komen met de door software automatisch bepaalde VDG groepen dan wanneer ra-
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diologen visueel de BI-RADS classificaties gebruiken. Daaruit concluderen we dat het
misschien beter is om de dichtheidsschattingen met software te doen dan in plaats van een
radioloog. Het voordeel van software is bovendien dat het resultaat altijd hetzelfde is (ten-
minste als het dezelfde algoritme gebruikt wordt), er is dus geen intralezervariabiliteit.
Softwarepakketten zoals Volpara bepalen zowel het borstklierweefselvolume als ook het
borstvolume op basis van een het mammogram, de instellingen van de apparatuur, bij-
voorbeeld het materiaal van de ro¨ntgenbuis en de elektrische spanning, en de dikte van
de gecomprimeerde borst. Ter verificatie van deze schatting, wordt de mammografische
dichtheid vaak vergelijken met de dichtheidsschatting uit MRI beelden. MRI is een beeld-
vormende techniek welke driedimensionale (3D) beelden van het lichaam kan maken, waar-
door het makkelijker en nauwkeuriger is om een volume te berekenen. Voor dit doel worden
voxels (3D versie van een pixel) met klierweefsel van voxels met vetweefsel onderscheiden.
Om het klierweefselvolume de berekenen gebruikt het Volpara algoritme voor elke mam-
mografische opname een aparte referentiewaarde. Daarvoor gaat het algoritme op zoek
naar de donkerste pixels in het mammogram. Het algoritme veronderstelt vervolgens dat
deze pixels bij de projectie van alleen vetweefsel horen. Deze veronderstelling klopt echter
niet altijd. Vooral in mammogrammen met veel klierweefsel is het onwaarschijnlijk dat
de gekozen referentiewaarde alleen vetweefsel representeert. Wanneer de gekozen referen-
tiewaarden niet bij de projectie van alleen vetweefsel hoort, wordt het klierweefselvolume
en vervolgens het klierweefselpercentage onderschat. Vandaar dat we in hoofdstuk 4 naar
een methode hebben gekeken om het klierweefselpercentage te bepalen. Voor mammo-
grammen met veel klierweefsel hebben we een andere methode ontwikkeld waarin juist
het tegendeel verondersteld wordt: Het algoritme bepaald de pixelwaarde van het lichtste
gedeelte in het mammogram en samen met een schatting van de hoeveelheid klierweefsel
dat bij deze pixelwaarde hoort wordt een referentie berekend die zou horen bij de projectie
van alleen vetweefsel. Er zijn vervolgens meerdere methodes, de ene werkt bij een lage
borstdichtheid, de andere veronderstelt een hoge borstdichtheid. Een combinatie van de
methodes geeft vervolgens een verbeterde schatting van het klierweefselpercentage.
Zoals eerder beschreven, neemt de sensitiviteit van de screening af naarmate de dichtheid
toeneemt. Dit komt door het zogenoemde ’maskeringseffect’ van borstklierweefsel. Tu-
mor en borstklierweefsel lijken in het mammogram op elkaar waardoor het lastig is voor
de radioloog om de tumor te detecteren. Om die reden wordt de kans groter dat kanker on-
opgemerkt blijft wanneer er veel klierweefsel aanwezig is. Vrouwen met veel klierweefsel
zouden dus het meest van een screening op maat profiteren. Om te beslissen wie aanvullend
onderzoek nodig heeft, moet het risico op maskering bepaald worden. In de praktijk zou het
risico van alle vrouwen met een negatief mammogram (vrouwen die niet zijn doorverwe-
zen) bepaald kunnen worden en als het risico boven een van tevoren bepaalde drempel ligt
zou aanvullend onderzoek aangeboden kunnen worden. Om de voor- en nadelen in even-
wicht te houden moet de risicoschatting en de drempel zodanig gekozen worden dat vooral
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vrouwen voor aanvullend onderzoek in aanmerking komen bij wie de kans op aanwezig-
heid van een borstkanker die niet in het mammogram te zien is het grootst is. Wanneer we
terugkijken naar het bevolkingsonderzoek zoals het tegenwoordig is, zijn de vrouwen met
een fout negatief mammogram (de vrouwen met een intervaltumor) degene die het meest
kunnen profiteren van aanvullend onderzoek. In samenhang hiermee moet wel genoemd
worden, dat niet alle intervalkankers door aanvullend onderzoek detecteerbaar zijn. Er zijn
ook kankers die tijdens het maken van het mammogram niet aanwezig waren en in loop
van het screeningsinterval zijn ontstaan. Deze intervalkankers zijn ook met andere beeld-
vormende technieken niet opspoorbaar. Voor onze database weten we helaas niet welke
intervalkankers er gemaskeerd waren en welke niet. Vandaar dat we veronderstellen dat
alle intervalkankers gemaskeerd waren die binnen 12 maanden na de screening zijn gedi-
agnosticeerd. De tijd om te groeien en voelbaar te worden wordt dus beperkt waardoor
de kans op een tumor die tijdens het screening niet aanwezig was geminimaliseerd wordt.
Vrouwen met een intervalkanker binnen 12 maanden zijn dus onze doelgroep, en we hebben
gezocht naar een manier om deze vrouwen te onderscheiden van vrouwen met een terecht
negatief mammogram. Want vrouwen zonder verdenking op een tumor en zonder kanker-
diagnose voorafgaand aan de volgende screeningsronde zouden geen aanvullend onderzoek
nodig hebben.
In hoofdstuk 5 hebben we gekeken in hoeverre BI-RADS, het percentage klierweefsel en
twee andere metingen in staat zijn deze twee groepen vrouwen te onderscheiden. We waren
voornamelijk geı¨nteresseerd in resultaten bij de transitie van BI-RADS b naar c, want dat
is de classificatie die in de kliniek en ook in het bevolkingsonderzoek in de VS gebruikt
wordt. Wanneer alle vrouwen met een BI-RADS categorie c of d aanvullend onderzoek
aangeboden zouden krijgen, is het nodig rond 39% van de bevolking een aanvullend scree-
ningsonderzoek aan te bieden. Wanneer vervolgens de drempel zodanig gekozen werd dat
39% van de bevolking aanvullend onderzoek krijgt, behoren significant meer vrouwen met
intervalkanker tot de interventiegroep met PDA (een van de andere automatische metingen
met de computer) dan met BI-RADS. Ook vergeleken met het percentage klierweefsel, zul-
len meer vrouwen met intervalkanker uitgenodigd zijn met PDA. Deze studie laat dus zien,
dat er naast borstdichtheid ook nog andere maten zijn om het maskeringseffect te meten en
dat deze misschien beter geschikt zijn voor een screening op maat.
Samenvattend zou borstdichtheid als stratificatiemethode gebruikt kunnen worden voor
borstkanker screening op maat, ten eerste omdat vrouwen met een hoge borstdichtheid
een verhoogd risico hebben op het ontwikkelen van borstkanker en omdat deze vrouwen
ook een grotere kans lopen een intervalkanker te ontwikkelen (hoofdstuk 2). Geautoma-
tiseerde borstdichtheidsschatting met software geeft consistentere borstdichtheidsbepalin-
gen in opeenvolgende screeningsmammogrammen dan radiologen die de visuele BI-RADS
classificatie gebruiken (hoofdstuk 3). BI-RADS wordt in de huidige praktijk het meest
gebruikt voor het benaderen van de borstdichtheid, echter blijkt uit ons onderzoek dat com-
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puter software beter geschikt is om het risico op een fout negatief mammogram te bepalen
(hoofdstuk 5). Doordat de BI-RADS classificatie slechts uit vier klassen bestaat is de kans
aanzienlijk dat het borstkankerrisico dat een vrouw loopt wordt onder- of overschat. Soft-
ware geeft een volumetrische bepaling op een continue schaal die gevoeliger zou kunnen
zijn voor het bepalen van de juiste screeningsmethodiek en dus een betere stratificatieme-
thode zou kunnen zijn. Hierbij dient men wel rekening te houden met vrouwen die op het
mammogram extreem veel borstklierweefsel hebben omdat huidige volumetrische automa-
tische methoden leiden tot een onderschatting van de borstdichtheid (hoofdstuk 4).
Desalniettemin is borstdichtheid niet de enige variabele voor screening op maat. In hoofd-
stuk 6 hebben we de invloed van compressie van de borst op de uitkomst van de screening
onderzocht. Tijdens het maken van een mammogram word de borst gecomprimeerd, om
bewegingsonscherpte, strooistraling en dosis te beperken en tevens overprojectie van borst-
klierweefsel te voorkomen. Elke borst word met min of meer dezelfde kracht gecompri-
meerd die onafhankelijk is van borstgrootte en borstdichtheid. Vrouwen, met name degene
met kleine borsten, vinden de compressie vaak erg pijnlijk. Voor sommige vrouwen is die
pijnlijke ervaring de voornaamste reden om niet (meer) aan het bevolkingsonderzoek deel
te nemen. Druk, gedefinieerd als kracht gedeeld door contactoppervlak met de compressie-
plaat, is een betere maat voor compressie omdat rekening gehouden wordt met borstgrootte,
borstdichtheid en stijfheid van de borst. We hebben gekeken of er een verband bestaat tus-
sen de sensitiviteit van het bevolkingsonderzoek en de druk die is uitgeoefend op de borst
tijdens het maken van een mammogram. Verder hebben we gekeken naar het aantal (onte-
recht) verwijzingen, de specificiteit en het aantal tumoren. Om dit te onderzoeken hebben
we eerst de vrouwen in onze dataset opgedeeld in vijf groepen op basis van de uitgevoerde
druk gedurende het vervaardigen van het mammogram. Vrouwen in de eerste groep onder-
vonden een lage druk tijdens het maken van het mammogram, vrouwen in de vijfde groep
juist een hoge druk. Uit ons onderzoek bleek dat vrouwen die in de eerste groep terecht
kwamen vaker onterecht worden doorverwezen voor vervolgonderzoek, kortom een fout-
positieve uitslag kregen. Deze bevinding ondersteunt dus de aanname dat een bepaalde druk
en dus compressie nodig is voor een goede beeldkwaliteit en de beoordeelbaarheid van het
mammogram. Vaak wordt in het bevolkingsonderzoek gedacht dat een hardere compressie
altijd beter is, omdat meer compressie leidt tot betere ro¨ntgenopnames en vervolgens tot
hogere detectiecijfers. Ons onderzoek laat echter zien dat bij vrouwen in de twee hoogste
drukgroepen meer interval carcinomen voorkomen. Dit resulteert in lagere sensitiviteit van
het bevolkingsonderzoek in de hogere drukgroepen vergeleken met de lagere drukgroepen.
Dus ook een te hoge druk heeft ongewenste nadelen. Een druk gestuurde compressie, een
compressie met een specifieke druk, zou zowel te veel druk en daarmee overcompressie,
als ook te weinig druk en daarmee ondercompressie kunnen voorkomen. Op basis van ons
onderzoek is het echter niet mogelijk een streefdruk te bepalen.
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Sowohl in den Niederlanden als auch in Deutschland, sowie in vielen anderen westlichen
La¨ndern, werden symptomfreie Frauen eingeladen alle zwei Jahre an dem Brustkrebs-
fru¨herkennungsprogramm teilzunehmen. Man bietet das Screening an, um den Brustkrebs
mo¨glichst fru¨h zu erkennen und die Heilungschancen, im Falle einer Erkrankung, zu erho¨-
hen, denn Brustkrebs ist die ha¨ufigste Krebsdiagnose bei Frauen. Im Screening werden
von jeder Brust zwei Ro¨ntgenaufnahmen erstellt. Diese werden dann von Radiologen im
Bezug auf eine mo¨gliche Abnormalita¨t beurteilt. Auch wenn mehrere Studien die Effekti-
vita¨t von Brustkrebsfru¨herkennungsprogrammen bewiesen haben, hat das Screening nicht
nur Vorteile. Zum einen werden mehr Frauen als no¨tig u¨ber einen mo¨glichen Befund infor-
miert, welcher sich nach weiteren Untersuchungen als gutartig oder als normales Gewebe
herausstellt (falsch positiver Befund). Zum anderen werden nicht alle Tumore innerhalb des
Fru¨herkennungsprogrammes entdeckt. Ungefa¨hr 16-32% der Tumore werden außerhalb des
Screenings diagnostiziert.
Das Fru¨herkennungsprogramm in seiner heutigen Form ist nicht fu¨r alle Frauen gleicher-
maßen effektiv. Daher wird u¨ber stratifiziertes Screening nachgedacht. Das Screeningpro-
gramm wu¨rde dann von dem Brustkrebsrisiko und dem Risiko, dass der Tumor nicht mit
Mammographie innerhalb des Screenings entdeckt werden ko¨nnte, abha¨ngen. Anstelle eines
Mammogrammes alle zwei Jahre, ko¨nnen anderen bildgebende Verfahren, zum Beispiel
Ultraschall oder MRT, eingesetzt werden. Auch ko¨nnte das Screeningintervall auf die indi-
viduellen Bedu¨rfnisse angepasst werden.
Noch ist nicht klar welche Parameter zur Stratifizierung verwendet werden ko¨nnen. Eine
Stratifizierung auf Basis der Brustdichte ist mo¨glich. Ha¨ufig wird die Brustdichte, die Men-
ge Dru¨sengewebe im Verha¨ltnis zur Brustgro¨ße, von Radiologen gescha¨tzt. Diese verwen-
den dazu den BI-RADS Atlas. In diesem wird die Brustdichte in vier Kategorien unter-
teilt. Problem der BI-RADS Kategorien ist jedoch die Inter- und Intra-Leser Variabilita¨t.
Die zugeordnete Kategorie variiert sowohl zwischen Radiologen als auch bei der Beur-
teilung der gleichen Person zu verschiedenen Zeitpunkten. Zudem stehen mehrere Algo-
rithmen zur Brustdichtemessung zur Verfu¨gung. Die meisten Algorithmen unterscheiden
dazu Dru¨sengewebe von Fettgewebe. Sowohl die absolute Menge Dru¨sengewebe (in cm3)
als auch die Menge Dru¨sengewebe im Verha¨ltnis zur Brustgro¨ße ko¨nnen zur Stratifizie-
rung herrangezogen werden. Die automatisierte Messung der Brustdichte wurde durch die
Einfu¨hrung der digitalen Mammographie vereinfacht.
Dass die Mammographie nicht fu¨r alle Frauen gleichermaßen geeignet ist, wird in Kapitel 2
sichtbar. Neben verschiedenen anderen Parametern wurde die Sensitivita¨t, der Anteil im
Screening diagnostizierte Tumore im Vergleich zu allen Brustkrebserkrankungen, in Bezug
auf die Brustdichte gemessen. Wir fanden heraus, dass die Sensitivita¨t abnimmt, wenn die
Brustdichte zunimmt. Zudem ist sichtbar, dass das Risiko an Brustkrebs zu erkranken mit
Zunahme der Brustdichte ansteigt. Frauen mit hoher Brustdichte haben somit nicht nur ein
erho¨htes Brustkrebsrisiko, sondern auch ein erho¨htes Risiko, dass der Tumor nicht inner-
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halb des Fru¨herkennungsprogramms erkannt wird. Diese Frauen wu¨rden somit am sta¨rksten
von einem stratifizierten Fru¨herkennungsprogramm profitieren.
In den letzten Jahren wurde in den USA auch außerhalb der Wissenschaft u¨ber Brust-
dichte diskutiert. Die “breast density laws” verpflichten Radiologen nun Frauen u¨ber ihre
Brustdichte und die damit einhergehenden Risiken zu informieren. Ha¨ufig unterscheidet
man lediglich Frauen mit viel Dru¨sengewebe (BI-RADS c und d) von solchen mit wenig
Dru¨sengewebe (BI-RADS a und b). Wenn man eine solche Klassifizierung zur Stratifizie-
rung in verschiedene Screeningregime verwenden will, ist es wichtig, dass die Klassifizie-
rung konsistent ist. Nicht nur im Bezug auf Inter- und Intra-Leser Reliabilita¨t, sondern auch
im Bezug auf temporelle Daten. Die Klassifizierung sollte sich nicht alle zwei Jahre, mit
jeder neuen Aufnahme, a¨ndern.
In Kapitel 3 wird die Klassifizierung in vier, beziehungsweise zwei, Gruppen von tem-
porellen Daten untersucht. Dazu wurden 500 Mammogrammpaare sowohl von Radiolo-
gen mit Hilfe des BI-RADS Atlas beurteilt als auch von vollautomatischer Software auf
ihre Brustdichte hin untersucht. Die Software (Volpara) bestimmt dazu das Volumen des
Dru¨sengewebes und das Brustvolumen. Anschließend wird der Prozentsatz Dru¨sengewebe
bestimmt, welcher zur Unterteilung in vier Kategorien (VDG) genutzt wird. Wir fanden her-
aus, dass in 86-91% der Fa¨lle beide Aufnahmen eines Paares zur gleichen Gruppe geho¨rten.
Zudem wurde untersucht wie konsistent die Dichtemessung ist, wenn die Mammogramme
eines Paares von verschieden Radiologen beurteilt wurden, wie es im Screening der Fall
ist. Es zeigte sich, dass die Messung mit der automatischen Software konsistenter als die
Simulation der Screeningsituation ist. Dies legt daher den Schluß nahe, dass die Software
besser geeigent ist die Brustdichte zu bestimmen.
Der BI-RADS Atlas ermo¨glicht eine Klassifizierung der Brustdichte in vier Kategorien.
Mit Software ist es jedoch mo¨glich, eine kontinuierliche Bestimmung der Brustdichte zu
erhalten. Die volumetrische Brustdichte Messung auf Basis eines Mammogrammes setzt
verschiedene Annahmen vorraus. Schließlich wird ein Volumen auf Basis eines zweidimen-
sionalen Bildes berechnet. Einer der bestehenden Algorithmen verwendet fu¨r jede Aufnahme
einen internen Referenzwert um die Brustdichte zu bestimmen. Dieser Referenzwert ist re-
pra¨sentativ fu¨r die dunkelste Stelle innerhalb der segmentierten Brust. Es wird angenom-
men, dass dieser Pixelwert zu der Projektion von Fettgewebe geho¨rt und dass sich kein
Dru¨sengewebe zwischen Strahlenquelle und dem Detektor befand. Diese Annahme stimmt
jedoch nicht, wenn man eine Aufnahme von einer Brust mit viel Dru¨sengewebe betrachtet.
Studien haben gezeigt, dass in diesem Fall die Brustdichte unterscha¨tzt wird. In diesen Stu-
dien wird die Brustdichtemessung in Mammographie-Aufnahmen mit der Brustdichtemes-
sung in MRT Aufnahmen verglichen. Die dreidimensionale MRT Aufnahme ermo¨glicht
eine genaue Bestimmung der Brustdichte in dem jedes Voxel (3D Version eines Pixels) als
Dru¨sengewebe oder Fettgewebe klassifiziert wird. Wenn MRT und Mammogramm inner-
halb weniger Wochen voneinander aufgenommen wurden, nimmt man an, dass die jeweils
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gemessene Brustdichte gleich sein sollte.
In Kapitel 4 werden drei Methoden zur Referenzwertbestimmung pra¨sentiert. In den ersten
beiden Methoden wird der Pixelwert, welcher zu der dunkelsten Stelle in der Aufnahme
geho¨rt, und somit representativ fu¨r die Projektion von aussschließlich Fettgewebe sein soll,
bestimmt. Dabei scheint die zweite Methode besser geeignet zu sein fu¨r Aufnahmen mit
mehr Dru¨sengewebe wa¨hrend die erste Methode gute Resultate liefert fu¨r Aufnahmen mit
sehr wenig Dru¨sengewebe. Die dritte Methode verwendet einen Pixelwert, der zu einer der
hellsten Regionen imMammogramm geho¨rt, um den Referenzwert zu bestimmen der zu der
Projektion von Fettgewebe geho¨ren wu¨rde und nicht in einem Mammogramm mit sehr viel
Dru¨sengewebe vorhanden ist. Diese alternative Methode ist no¨tig, wenn der Referenzwert
bestimmt mit den ersten Methoden nicht representativ fu¨r die Projektion von Fettgewebe
ist. Da die erste Methode sehr gut bei Mammogrammen mit wenig Dru¨sengewebe funktio-
niert und die anderen beiden Methoden entwickelt wurden unter der Annahme, dass viel
Dru¨sengewebe vorhanden ist, liefert eine Kombination der Methoden die besten Resultate,
im Vergleich zu der Dichtemessung der MRT Aufnahmen.
In Kapitel 2 zeigten wir, dass die Sensitivita¨t mit Zunahme der Brustdichte abnimmt und
dass das Brustkrebsrisiko zunimmt. Auf Grund dieser Gegebenheiten bekommen Frauen in
manchen Staaten in den USA schon zusa¨tzliche bildgebenden Verfahren angeboten. Der-
zeit entscheidet lediglich die Brustdichte, gescha¨tzt mit BI-RADS oder Software, wer fu¨r
zusa¨tzliches Screening in Frage kommt. Das Risiko auf “Maskierung” wird noch nicht eva-
luiert. Der “Maskierungseffekt” beschreibt die Tatsache, dass Tumorgewebe und Dru¨sen-
gewebe auf demMammogramm gleich aussehen, und dass im Falle von viel Dru¨sengewebe
es nicht mo¨glich ist die beiden voneinander zu unterscheiden. Der Tumor hat sozusagen
eine “Maske” auf und verschleiert sein wahres Gesicht. Durch die Maskierung wird der
Tumor nicht innerhalb des Screenings sondern stattdessen zwischen zwei Screeningrunden
entdeckt. Auch wenn das Maskierungsrisiko mit Zunahme der Brustdichte zunimmt, heißt
dies nicht, dass Brustdichte das beste Maß fu¨r den Maskierungseffekt ist. Um den Mas-
kierungseffekt zu messen, haben wir in Kapitel 5 zurecht negative Mammogrammen mit
falsch negativen Mammogrammen (Mammogrammen von Frauen, welche nicht durchver-
wiesen wurden und welche dennoch innerhalb von 12 Monaten nach den Aufnahmen eine
Brustkrebsdiagnose erhielten) verglichen. Das ideale Maß fu¨r denMaskierungseffekt wu¨rde
alle Frauen, die spa¨ter einen Intervalltumor diagnostiziert bekommen, identifizieren. Durch
die Annahme, dass der Tumor schon vorhanden ist, wu¨rden diese Frauen am meisten von
zusa¨tzlichen Screeningmaßnahmen profitieren. In besagtemKapitel haben wir verschiedene
Maße auf die Eigenschaft hin verglichen, falsch negative Mammogramme von zurecht ne-
gativen Aufnahmen zu trennen. Zum einen wurden alle Mammogramme von einem Radio-
logen mit Hilfe des BI-RADS Atlas beurteilt, auch wurde in allen Mammogrammen die
Brustdichte mit Software gemessen. Zwei weitere pra¨sentierte Methoden verwenden eine
Dichtekarte. Die Dichtekarte ist vergleichbar mit einer Ho¨henkarte und gibt fu¨r jede Positi-
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on in demMammogramm dieMenge von Dru¨sengewebe (in cm) an. Das ersteMaß ist PDA,
der Prozentsatz der Pixel mit einem Dru¨sengewebeanteil von mehr als 1 cm. Das zweite
Maß (DTMM) verwendete die Dichtekarte in Kombination mit der Tumorgro¨ßenverteilung
innerhalb des Screenings. Letztere Methode verwendet unter anderem das Wissen, dass das
Risiko zunimmt, wenn die Menge Dru¨sengewebe zunimmt und dass das Risiko auf Mas-
kierung abnimmt, wenn die Tumorgro¨ße zunimmt. Vorallem die automatisierte Messung
PDA ist im Vergleich zur Klassifizierung mit BI-RADS besser geeignet um Frauen mit
zuku¨nftigem Intervalltumor von Frauen mit zurecht negativem Befund zu unterscheiden,
angenommen, dass Frauen mit der BI-RADS Kategorien c und d ein erho¨htes Risiko haben
und dass dementsprechend ungefa¨hr 38.5% der Frauen fu¨r zusa¨tzliche bildgebende Verfah-
ren in Betracht kommen.
Um die Strahlenbelastung zu verringern, Gewebeschichten zu trennen und Bewegungs-
effekte zu vermeiden, wird die Brust wa¨hrend der Mammographie zusammengedru¨ckt.
Die Kompression wird von vielen Frauen als schmerzhaft empfunden und ist einer der
ha¨ufigsten Gru¨nde nicht am Screening teilzunehmen. Ein Maß fu¨r die Kompression ist
Kraft, welche auch in den Metainformationen einer jeden Aufnahme gespeichert wird.
Die Vorgehensweise bei der Brustkompression ist hinsichtlich der Kompressionskraft je-
doch nicht standardisiert. Ein besseres Maß fu¨r die Kompression ko¨nnte Druck sein. Druck
ist definiert als Kraft geteilt durch Oberfla¨che. Um den Druck der Brustkompression zu
berechnen dividiert man die gemessene Kraft durch die Kontaktoberfla¨che, die Fla¨che in
der die Brust die Kompressionsplatte beru¨hrt. Diese kann mit Hilfe von Software berechnet
werden. Wa¨hrend die Kraft unabha¨ngig von den Gegebenheiten der Brust ist, wird in der
Druckmessung die Brustgro¨ße und Dichte einbezogen. Eine große Brust, die vorallem aus
Fettgewebe besteht, nimmt eine gewisse Kraft anders wahr als eine kleine Brust. In Kapi-
tel 6 wird die Qualita¨t des Screeningprogrammes im Hinblick auf Kompression beurteilt.
Dazu wurden die Mammogramme auf fu¨nf Gruppen verteilt, sodass jede Gruppe gleich
viele Mammogramme beinhaltete und der Druck mit jeder Gruppe zunahm. Anschließend
wurde fu¨r jede Gruppe die Sensitivita¨t, Verweißrate, Inzidenzraten und a¨hnliche Parameter
berechnet. Es scheint, dass in der ersten Gruppe, welcheMammogramemit geringemDruck
beinhaltet, Frauen ha¨ufiger u¨ber einen mo¨glichen Befund informiert werden, der sich an-
schließend als falscher Alarm herausstellt. Dies zeigt, dass eine gewisse Kompression not-
wendig ist um verschiedene Gewebeschichten ausreichend zu trennen und eine gute Bild-
qualita¨t zu gewa¨hrleisten. Andererseits nimmt die Sensitivita¨t in den letzten beiden Gruppen
ab. Eine zu starke Kompression scheint den Kontrast zwischen verschiedenen Geweben zu
verringern wodurch Tumore weniger verda¨chtig erscheinen. Dies ha¨ngt vielleicht mit einer
reduzierten Blutzufuhr zusammen. Vielleicht gibt es einen Optimaldruck, der sowohl eine
zu niedrige als auch zu starke Kompression verhindert. Weitere Forschungen auf diesem
Gebiet sind dazu notwendig.
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Zusammenfassend: Brustdichte ist ein bekannter Brustkrebsrisikofaktor. Frauen mit ho-
her Brustdichte haben ein erho¨htes Brustkrebsrisiko und ein erho¨htes Risiko, dass der Tu-
mor nicht innerhalb des Brustkrebsfru¨herkennungsprogrammes erkannt wird. Diese Frau-
en wu¨rden daher am sta¨rksten von einem stratifizierten Screening profitieren. Die Brust-
dichte kann auf verschiedene Weisen gemessen werden. Dabei gilt es zu beachten, dass der
Prozentsatz Dru¨sengewebe leicht unterscha¨tzt werden kann, vorallem in Aufnahmen mit
viel Dru¨sengewebe. Anstelle einer kontinuierlichen Messung der Brustdichte ko¨nnen auch
Brustdichtegruppen verwendet werden. Eine Klassifizierung mit Software verhindert Inter-
und Intra-Leser Variabilita¨t und klassifiziert temporelle Daten konsistenter im Vergleich zu
der Beurteilung des Radiologen. Auch wenn die Brustdichtemessung inzwischen weit ver-
breitet ist, andere Messungen sind mo¨glicherweise besser geeignet Mammogramme von
Frauen mit zuku¨nftigen Intervalltumoren von zurecht negativen Aufnahmen zu unterschei-
den, als die hier untersuchten Brustdichtegruppen und der Prozentsatz Dru¨sengewebe. Die
Einfu¨hrung eines Idealdrucks ko¨nnte zudem vielleicht unno¨tige U¨berweisungen und Inter-
valltumore verhindern.
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